Reported tuberculosis in the United States, 1999 by National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
REPORTED TUBERCULOSIS IN
THE UNITED STATES, 1999
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
Centers for Disease Control and Prevention
National Center for HIV, STD, and TB Prevention
Division of Tuberculosis Elimination
Atlanta, Georgia 30333
Tuberculosis Case Rates: United States, 1999
Rate per
100,000 Population
<3.5 (year 2000 target)
3.6 - 6.4
>6.4 (national average)
PR
HI
DC
1Introduction
      Reports of tuberculosis (TB) cases are submitted to the Division of TB Elimination (DTBE),
Centers for Disease Control and Prevention (CDC), by 60 reporting areas (the 50 states, the District of
Columbia, New York City, Puerto Rico, and other jurisdictions in the Pacific and Caribbean).  In
January 1993, DTBE, in conjunction with state and local health departments, implemented an expanded
TB surveillance system.  The expanded system collects additional information for each reported TB
case in order to better monitor trends in TB, including drug-resistant TB, in the United States.  A
software package (SURVS-TB) for data entry, analysis, and transmission of case reports to CDC was
designed and implemented as part of the expanded TB surveillance system.  In 1998, the Tuberculosis
Information Management System (TIMS) replaced SURVS-TB in order to provide reporting areas
with a comprehensive software for surveillance, patient management, and program evaluation. 
      This publication, Reported Tuberculosis in the United States, 1999, presents summary data for
TB cases reported to DTBE during 1999.  It is similar to previous publications (page 5, #19) and
contains six major sections.  The first section is new this year and presents trends in the overall TB case
counts and case rates by selected demographic and clinical characteristics.  In addition to Table 1,
which presents data from 1953 to the present, Tables 2 through 6 present data for the past 11 years,
and Tables 7 through 10 present data collected since implementation of the expanded system in 1993,
including drug resistance and clinical outcomes. 
      The second section (Tables 11 through 14) presents overall case counts and rates by selected
demographic characteristics for 1999.  In the third section, TB case counts and case rates are
presented by state with tables of selected demographic and clinical characteristics.  In the fourth
section, data collected as part of the expanded system (e.g., initial drug resistance, HIV status) are
presented by reporting area.  The fifth section provides TB case counts and case rates by metropolitan
statistical areas (MSAs: see Technical Notes, Appendix A, for further details) with tables of selected
demographic and clinical characteristics.  Finally, the sixth section is a revision of the collection of
figures presented in previous years.  This year, figures from the annual surveillance slide set, which
emphasize key recent trends in TB epidemiology in the United States, are included.  The slides with
accompanying text can also be viewed and downloaded from the Division Home Page which is
accessible via the Internet: www.cdc.gov/nchstp/tb.
      To help interpret the data, an Executive Commentary (page 2) and Technical Notes (Appendix A)
have been included.  In addition, the current case definition (MMWR 1997;46 [No. RR-10]:40-1) and
“Recommendations for Counting Reported Tuberculosis Cases” are provided in Appendices B and C,
respectively.  The recommendations for counting TB cases, which update the January 1977
recommendations, were first published in Reported Tuberculosis in the United States, 1996.  
      We will continue to adapt and improve this publication to better monitor trends in TB in the United
States.  Your comments and suggestions that may assist us in this process will be greatly appreciated. 
 
Executive Commentary     
   
      During 1999, a total of 17,531 TB cases (6.4 cases per 100,000 population) were reported to 
CDC from the 50 states and the District of Columbia, representing a 5% decrease from 1998 and 
a 34% decrease from 1992, when the number of cases peaked during the resurgence of TB in the 
United States.  The national TB case rate also steadily decreased during this period (Table 1).  In 
1999, 6% of cases were reported in children under 15 years old, 9% in persons aged 15-24 years, 
35% in persons aged 25-44 years, 28% in persons aged 45-64 years, and 23% in persons aged 65 
years and older (Table 2).  During 1992-1999, there was a decline in both the number of cases 
reported in each of these age groups and the respective TB case rates. 
       An important consideration is that the overall national trends reflect the impact of varying 
changes within population subgroups.  For example, the overall decrease in TB cases during 
1992-1999 primarily reflected a 49% decrease in the number of cases among U.S.-born persons, 
with substantial declines in all age groups.  In contrast, the total number of cases among 
foreign-born persons increased 4% during this period, reflecting a small increase among adults 
aged 25-44 years, a larger increase among adults aged $45 years, and a substantial decline among 
children aged <15 years.  In terms of case rates, there was a 51% decrease in the case rate among 
U.S.-born persons (from 8.2 to 4.0 per 100,000), and there was a 15% decrease in the case rate 
among foreign-born persons (from 34.5 to 29.2 per 100,000), (Table 4). 
       The overall trends also reflect the impact of changes by geographic location.  For example, 
during 1992-1999, the seven states (California, Florida, Georgia, Illinois, New Jersey, New York, 
and Texas) reporting the highest number of cases (59% of the total number of U.S. cases in 1999) 
experienced a substantial decrease in both the annual number of reported cases and case rate.  
Overall substantial decreases also occurred in 15 other states during the 8 year period.  In the 
remaining 28 states and the District of Columbia, annual case counts fluctuated (e.g. an increase 
followed by a decrease) or remained relatively stable during 1992-1999.  A majority of these (19 
states) had case rates below 3.5 per 100,000 (15 states) or reported less than 100 cases (17 states) 
in 1999.  
       The resurgence of TB in the United States in the late 1980s and early 1990s was associated 
with the emergence of multidrug-resistant TB (MDR TB) and the HIV/AIDS epidemic.1,2  Based 
on initial drug susceptibility test results for isolates from persons with culture-positive TB, 
resistance to at least isoniazid during 1993-1999 was relatively stable and MDR TB decreased 
substantially.  In 1999, 8% of isolates were resistant to at least isoniazid and 1% were resistant to 
at least isoniazid and rifampin (MDR TB) (Table 30).  The decrease in the level of MDR TB was 
influenced by a substantial decrease in New York City; however, during 1993-1999, the 
proportion of MDR TB cases reported from U.S. areas excluding New York City decreased from 
1.7% to 1%.  Trends in primary resistance, based on results for isolates from persons with no 
prior history of TB, were similar (Table 7).   
       Incomplete reporting has limited the analysis of national TB surveillance data by HIV status. 
 Reporting of HIV status has improved slowly since 1993, the year such information was first 
included on TB case reports submitted to CDC.  In 1999, 57% of TB case reports for persons 
aged 25-44 years included information about HIV status.  Twenty-three states, New York City, 
and the District of Columbia reported this information for at least 75% of cases among persons in 
this age group (Table 31).   To help estimate the proportion of reported TB cases with HIV 
coinfection, state health departments have compared TB and AIDS registries.3  Using registry 
match data to supplement reported HIV test results on the individual TB case report, minimum 
estimates of the proportion with HIV coinfection range from 15% in 1993-1994 to 10% in 1998 
for persons of all ages reported with TB and from 29% in 1993-1994 to 20% in 1998 for persons 
aged 25 to 44 (Table 10).  The impact of the HIV/AIDS epidemic also differs by geographic 
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location.  For example, in 1999, over one-third of TB cases in persons aged 25-44 years reported 
from the District of Columbia, Florida, Georgia, New York City, and South Carolina were 
coinfected with HIV, whereas (among states with more than 5 cases in this age group), <10% of 
cases from Arkansas, Colorado, Mississippi, South Dakota, and Wisconsin were reported with 
HIV coinfection.  
       During 1992-1999, the declines in the overall number of reported TB cases and in the level of 
MDR TB appear to reflect successful efforts to strengthen TB control following the resurgence of 
TB and the emergence of MDR TB.  Emphasizing the first priority of TB control4 (i.e., promptly 
identifying persons with TB, initiating appropriate therapy, and ensuring completion of therapy) 
has likely been the most important factor in achieving this improvement, through the reduction of 
community transmission of M. tuberculosis, particularly in areas with a high incidence of AIDS.5 
  Improvements in infection control practices in nosocomial and other congregate settings, 
declining AIDS incidence, and the decreasing number of MDR TB cases also appear to have 
contributed to the overall decrease; however, the contribution of these factors has been difficult to 
measure.  The substantial decline in both the number of reported cases among U.S.-born persons 
and the case rate for U.S.-born persons supports these inferences.  In comparison, the relatively 
stable number of reported cases among foreign-born persons along with the modest decline in the 
case rate among foreign-born persons is consistent with other analyses of TB surveillance data 
that indicate that most cases of TB among foreign-born persons residing in the United States 
result from infection with M. tuberculosis in the person=s country of birth.6  As the percentage of 
reported TB cases among foreign-born persons continues to increase, the elimination of TB in the 
United States will depend increasingly on the elimination of TB among foreign-born persons.7  
CDC, in collaboration with state and local health departments, has published recommendations 
for enhancing TB control efforts in the foreign-born,7 and is currently working with these 
jurisdictions to expand efforts based on these recommendations.   
       To move from TB control to TB elimination in the United States, the Advisory Council for 
the Elimination of Tuberculosis has emphasized that existing efforts must be sustained and 
enhanced.8  The recent report from the Institute of Medicine, Ending Neglect: The Elimination of 
Tuberculosis in the United States, highlights the important question that now confronts the nation, 
Awhether another cycle of neglect will be allowed to begin, or whether, instead, decisive action 
will be taken to eliminate the disease.@9  The expanded national TB surveillance system has 
proven its usefulness in assisting in the evaluation of the success of TB control efforts and 
monitoring the status of the epidemic, particularly through the collection of data on initial drug 
susceptibility results.10  Information on the use of initial regimens of four first-line drugs, directly 
observed therapy, and completion of therapy in 1 year or less (Table 9) provides additional 
evidence to use in evaluating program success.  As future efforts accelerate towards TB 
elimination, maintaining and adapting surveillance systems at the national, state, and local levels 
will remain critical to monitoring the burden and impact of TB, evaluating success of control and 
prevention efforts, and directing policy and planning development.  
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Table 1. Tuberculosis Cases and Case Rates per 100,000 Population, 
Deaths and Death Rates per 100,000 Population: United States, 1953-1999 
Tuberculosis Cases Tuberculosis Deaths 
Percent Change Percent Change 
Year Number Rate 1 Number Rate Number Rate 1  Number Rate 
1953 84,304 - - - -53.0 19,707 12.4 - - - -
1954 79,775 49.3 -5.4 - 7.0 16,527 10.2 -16.1 -17.7 
1955 77,368 46.9 -3.0 - 4.9 15,016 9.1 - 9.1 -10.8 
1956 69,895 41.6 -9.7 -11.0 14,137 8.4 - 5.9 - 7.7 
1957 67,149 39.2 -3.9 - 5.8 13,390 7.8 - 5.3 - 7.1 
1958 63,534 36.5 -5.4 - 6.9 12,417 7.1 - 7.3 - 9.0 
1959 57,535 32.5 -9.4 -11.0 11,474 6.5 - 7.6 - 8.5 
1960 55,494 30.8 -3.5 - 5.2 10,866 6.0 - 5.3 - 7.7 
1961 53,726 29.4 -3.2 - 4.5 9,938 5.4 - 8.5 -10.0 
1962 53,315 28.7 -0.8 - 2.4 9,506 5.1 - 4.3 - 5.6 
1963 54,042 28.7 +1.4 0.0 9,311 4.9 - 2.1 - 3.9 
1964 50,874 26.6 -5.9 - 7.3 8,303 4.3 -10.8 -12.2 
1965 49,016 25.3 -3.7 - 4.9 7,934 4.1 - 4.4 - 4.7 
1966 47,767 24.4 -2.5 - 3.6 7,625 3.9 - 3.9 - 4.9 
1967 45,647 23.1 -4.4 - 5.3 6,901 3.5 - 9.5 -10.3 
1968 42,623 21.3 -6.6 - 7.8 6,292 3.1 - 8.8 -11.4 
1969 39,120 19.4 -8.2 - 8.9 5,567 2.8 -11.5 - 9.7 
1970 37,137 18.3 -5.1 - 5.7 5,217 2.6 - 6.3 - 7.1 
1971 35,217 17.1 -5.2 - 6.6 4,501 2.2 -13.7 -15.4 
1972 32,882 15.8 -6.6 - 7.6 4,376 2.1 - 2.8 - 4.5 
1973 30,998 14.8 -5.7 - 6.3 3,875 1.8 -11.4 -14.5 
1974 30,122 14.2 -2.8 - 4.1 3,513 1.7 - 9.3 - 5.6 
1975 33,989 -- --15.9 3,333 1.6 - 5.1 - 5.9 
1976 32,105 15.0 -5.5 - 5.7 3,130 1.5 - 6.1 - 6.3 
1977 30,145 13.9 -6.1 - 7.3 2,968 1.4 - 5.2 - 6.7 
1978 28,521 13.1 -5.4 - 5.8 2,914 1.3 - 1.8 - 7.1 
1979 27,669 12.6 -3.0 - 3.8 2,007 2 0.9 2 -31.1 2 -30.8 2 
1980 27,749 12.3 +0.3 - 2.4 1,978 0.9 - 1.4 0.0 
1981 27,373 11.9 -1.4 - 3.3 1,937 0.8 - 2.1 -11.1 
1982 25,520 11.0 -6.8 -7.6 1,807 0.8 - 6.7 0.0 
1983 23,846 10.2 -6.6 - 7.3 1,779 0.8 - 1.5 0.0 
1984 22,255 9.4 -6.7 - 7.8 1,729 0.7 - 2.8 -12.5 
1985 22,201 9.3 -0.2 - 1.1 1,752 0.7 + 1.3 0.0 
1986 22,768 9.4 +2.6 + 1.1 1,782 0.7 + 1.7 0.0 
1987 22,517 9.3 -1.1 - 1.1 1,755 0.7 - 1.5 0.0 
1988 22,436 9.1 -0.4 - 2.2 1,921 0.8 + 9.5 +14.3 
1989 23,495 9.5 +4.7 + 4.4 1,970 0.8 + 2.6 0.0 
1990 25,701 10.3 +9.4 + 8.4 1,810 0.7 - 8.1 -12.5 
1991 26,283 10.4 +2.3 + 1.0 1,713 0.7 - 5.4 0.0 
1992 26,673 10.5 +1.5 + 1.0 1,705 0.7 - 0.5 0.0 
1993 25,287 9.8 -5.2 - 6.7 1,631 0.6 - 4.3 -14.3 
1994 24,361 9.4 -3.7 -4.1 1,478 0.6 - 9.4 0.0 
1995 22,860 8.7 -6.2 -7.4 1,336 0.5 - 9.6 -16.7 
1996 21,337 8.0 -6.7 + 8.0 1,202 0.5 -10.0 0.0 
1997 19,851 7.4 -7.0 -7.5  1,166 0.4 -3.0 -20.0 
1998 18,361 6.8 -7.5 -8.1 1,110 3 0.4 3 -4.8 3 0.0 3 
1999 17,531 6.4 -4.5 -5.9 … … … … 
1. Per 100,000 population. 
2. The large decrease in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleurisy with 
effusion (without mention of cause) are no longer included in tuberculosis deaths. 
3. Preliminary data obtained from National Center for Health Statistics (NCHS) National Vital Statistics Reports, Vol. 47, No. 25, 
October 5, 1999. 
Ellipses indicate data not available.

Note: Case data after 1974 are not comparable to prior years due to changes in the surveillance case definitions which became 

effective in 1975.

See Surveillance Slide #2.
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Table 2. Tuberculosis Cases and Case Rates per 100,000 Population by Age Group: 
United States, 1989-1999 
Total 0 -14 15 - 24 25 - 44 45 - 64 65+ Not Stated 
Year Cases  No. (%) Rate  No. (%) Rate  No. (%) Rate  No. (%) Rate  No. (%) Rate No. (%) 
1989 23,495 1,321 (6) 2.5 1,742 (7) 4.8 8,549 (36) 10.6 5,777 (25) 12.4 6,096 (26) 19.7 10 (0) 
1990 25,701 1,596 (6) 3.0 1,867 (7) 5.1 9,730 (38) 12.0 6,365 (25) 13.7 6,115 (24) 19.6 28 (0) 
1991 26,283 1,662 (6) 3.0 1,971 (7) 5.4 10,263 (39) 12.5 6,297 (24) 13.5 6,068 (23) 19.1 22 (0) 
1992 26,673 1,707 (6) 3.1 1,974 (7) 5.5 10,444 (39) 12.7 6,487 (24) 13.4 6,025 (23) 18.7 36 (0) 
1993 25,287 1,718 (7) 3.0 1,841 (7) 5.1 9,615 (38) 11.6 6,225 (25) 12.5 5,847 (23) 17.8 41 (0) 
1994 24,361 1,695 (7) 3.0 1,825 (7) 5.1 9,106 (37) 11.0 6,141 (25) 12.1 5,546 (23) 16.7 48 (0) 
1995 22,860 1,558 (7) 2.7 1,703 (7) 4.7 8,241 (36) 9.9 5,998 (26) 11.5 5,351 (23) 16.0 9 (0) 
1996 21,337 1,372 (6) 2.4 1,656 (8) 4.6 7,604 (36) 9.1 5,588 (26) 10.4 5,103 (24) 15.1 14 (0) 
1997 19,851 1,265 (6) 2.2 1,681 (8) 4.6 6,912 (35) 8.3 5,297 (27) 9.6 4,691 (24) 13.8 5 (0) 
1998 18,361 1,082 (6) 1.9 1,548 (8) 4.2 6,365 (35) 7.6 4,973 (27) 8.7 4,393 (24) 12.8 0 (0) 
1999 17,531 1,044 (6) 1.8 1,516 (9) 4.0 6,078 (35) 7.3 4,862 (28) 8.2 4,028 (23) 11.7 3 (0) 
Note: Denominators for computing rates were based on official post-census estimates from the U.S. Census Bureau.

See Technical Notes (Appendix A).

See Surveillance Slide #5.

Table 3. Tuberculosis Cases and Case Rates per 100,000 Population by Race/Ethnicity: 
United States, 1989-1999 
White, Black, American Indian/ Asian/ Unknown/ 
Total non-Hispanic non-Hispanic  Hispanic1 Alaskan Native Pacific Islander Missing 
Year Cases  No. (%) Rate  No. (%) Rate  No. (%) Rate No. (%) Rate  No. (%) Rate No. (%) 
1989 23,495 7,638 (33) 4.0 8,743 (37) 29.5 3,958 (17) 19.3 344 (1) 19.8 2,738 (12) 39.8 74 (0) 
1990 25,701 7,836 (30) 4.2 9,634 (37) 33.0 4,809 (19) 21.5 361 (1) 20.1 3,004 (12) 43.1 57 (0) 
1991 26,283 7,709 (29) 4.1 9,536 (36) 31.9 5,354 (20) 22.9 342 (1) 18.5 3,324 (13) 44.3 18 (0) 
1992 26,673 7,618 (29) 4.0 9,623 (36) 31.7 5,437 (20) 22.4 299 (1) 16.2 3,649 (14) 46.3 47 (0) 
1993 25,287 6,922 (27) 3.6 8,951 (35) 29.1 5,194 (21) 20.6 274 (1) 14.6 3,680 (15) 44.5 266 (1) 
1994 24,361 6,494 (27) 3.4 8,345 (34) 26.8 5,074 (21) 19.5 332 (1) 17.4 3,821 (16) 45.3 295 (1) 
1995 22,860 5,989 (26) 3.1 7,555 (33) 23.9 4,847 (21) 18.0 319 (1) 16.5 3,997 (17) 45.9 153 (1) 
1996 21,337 5,506 (26) 2.8 7,106 (33) 22.3 4,533 (21) 16.0 284 (1) 14.5 3,814 (18) 41.6 94 (0) 
1997 19,851 4,872 (25) 2.5 6,610 (33) 20.5 4,228 (21) 14.4 264 (1) 13.4 3,833 (19) 40.6 44 (0) 
1998 18,361 4,495 (24) 2.3 5,831 (32) 17.8 4,099 (22) 13.6 253 (1) 12.6 3,623 (20) 36.6 60 (0) 
1999 17,531 4,224 (24) 2.2 5,552 (32) 16.8 3,875 (22) 12.4 240 (1) 11.8 3,591 (20) 35.3 49 (0) 
1. Persons of Hispanic origin may be of any race.

Note: Denominators for computing rates were based on official post-census estimates from the U.S. Census Bureau.

See Technical Notes (Appendix A).

See Surveillance Slide #7.
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Table 4. Tuberculosis Cases and Case Rates per 100,000 Population by 
Origin: United States, 1989-1999 
Total U.S.-born Persons Foreign-born Persons1 Unknown 
Year Cases No. % Rate No. % Rate No. % 
1989 23,495 17,646 75 … 5,411 23 … 438 2 
1990 25,701 18,997 74 8.3 6,262 24 31.2 442 2 
1991 26,283 19,161 73 8.2 6,982 27 33.9 140 1 
1992 26,673 19,225 72 8.2 7,270 27 34.2 178 1 
1993 25,287 17,464 75 7.4 7,354 29 33.6 469 2 
1994 24,361 16,278 67 6.8 7,627 31 33.9 456 2 
1995 22,860 14,772 65 6.1 7,930 35 34.2 158 1 
1996 21,337 13,333 62 5.5 7,704 36 32.3 300 1 
1997 19,851 11,898 60 4.9 7,702 39 31.2 251 1 
1998 18,361 10,675 58 4.3 7,591 41 30.0 95 1 
1999 17,531 9,809 56 4.0 7,553 43 29.2 169 1 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 

Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the 

Republic of Palau, U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.

Ellipses indicate data not available.

Note:  Denominators for computing rates were obtained from Quarterly Estimates of the United States Foreign-born 

and Native Resident Populations: April 1, 1990, to July 1, 1999 

(www.census.gov/population/estimates/nation/nativity/fbtab001.txt). 
See Surveillance Slides #9 and #12. 
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Table 5. Tuberculosis Cases by Case Verification Criterion and by Site of Disease: United 

States, 1989-1999

Verification Criterion1 Site of Disease 
Positive Positive Clinical Provider Extra-
Total Culture Smear Case Definition Diagnosis Pulmonary2 pulmonary 
Year Cases No. % No. % No. % No. % No. % No. % 
1989 23,495 19,483 83 351 1 2,475 11 1,186 5 19,639 84 3,835 16 
1990 25,701 20,897 81 556 2 2,958 12 1,290 5 21,576 84 4,091 16 
1991 26,283 21,417 81 388 1 2,992 11 1,486 6 21,937 83 4,327 16 
1992 26,673 21,398 80 407 2 3,141 12 1,727 6 22,371 84 4,288 16 
1993 25,287 20,081 79 309 1 2,994 12 1,903 8 21,255 84 3,995 16 
1994 24,361 19,537 80 236 1 2,794 11 1,794 7 20,385 84 3,964 16 
1995 22,860 18,292 80 220 1 2,664 12 1,684 7 18,991 83 3,860 17 
1996 21,337 17,234 81 150 1 2,556 12 1,397 7 17,445 82 3,870 18 
1997 19,851 16,015 81 177 1 2,355 12 1,304 7 16,285 82 3,554 18 
1998 18,361 14,830 81 166 1 2,207 12 1,158 6 14,813 81 3,541 19 
1999 17,531 13,997 80 176 1 2,058 12 1,300 7 14,083 80 3,438 20 
1. Based on the public health surveillance case definition for tuberculosis: CDC. Case definitions for infectious conditions under public 
health surveillance. MMWR 1997:46(No. RR-10):40-41. See Appendix B. 
2. Includes cases of both pulmonary and extrapulmonary disease and cases of miliary TB. 
Note: See Technical Notes (Appendix A) for a description of national TB surveillance. 
Table 6. Pulmonary Tuberculosis Cases by Sputum Smear and Sputum Culture Results: 

United States, 1989-1999

Sputum Smear Results Sputum Culture Results 
Total Not Done or Not Done or 
Pulmonary Positive Negative Unknown Positive Negative Unknown 
Year Cases1 No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
1989 19,639 8,759 (45) 5,924 (30) 4,956 (25) 13,712 (70) 1,908 (10) 4,019 (20) 
1990 21,576 9,391 (44) 6,865 (32) 5,320 (25) 14,816 (69) 2,124 (10) 4,636 (21) 
1991 21,937 9,095 (41) 7,281 (33) 5,561 (25) 15,022 (68) 2,232 (10) 4,683 (21) 
1992 22,371 8,975 (40) 7,413 (33) 5,983 (27) 15,124 (68) 2,476 (11) 4,771 (21) 
1993 21,255 9,324 (44) 7,747 (36) 4,184 (20) 14,708 (69) 2,675 (13) 3,872 (18) 
1994 20,385 8,845 (43) 7,770 (38) 3,770 (18) 14,080 (69) 2,618 (13) 3,687 (18) 
1995 18,991 8,068 (42) 7,717 (41) 3,206 (17) 13,236 (70) 2,597 (14) 3,158 (17) 
1996 17,445 7,449 (43) 7,337 (42) 2,659 (15) 12,232 (70) 2,507 (14) 2,706 (16) 
1997 16,285 6,882 (42) 6,878 (42) 2,525 (16) 11,481 (71) 2,226 (14) 2,578 (16) 
1998 14,813 6,630 (45) 6,016 (41) 2,167 (15) 10,472 (71) 2,101 (14) 2,240 (15) 
1999 14,083 6,252 (44) 5,626 (40) 2,205 (16) 9,777 (69) 2,049 (15) 2,257 (16) 
1. Includes cases of both pulmonary and extrapulmonary disease and cases of miliary TB. 
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Table 7. Resistance to Isoniazid with or without Rifampin Resistance in Reported TB Cases 
with No Previous TB by Origin: United States, 1993-1999 
Resistant to Isoniazid1 Resistant to Isoniazid and Rifampin1 
Total Cases2 U. S.-born Foreign-born3 Total Cases2  U. S.-born  Foreign-born3 
Year No. % No. % No. % No.  % No. % No. % 
1993 1,400 8.4 804 6.8 579 12.4 410 2.5 302 2.6 105 2.3 
1994 1,355 8.3 709 6.5 632 12.1 352 2.2 238 2.2 109 2.1 
1995 1,171 7.3 554 5.4 615 11.0 252 1.6 168 1.6 84 1.5 
1996 1,134 7.4 492 5.2 638 11.3 205 1.3 103 1.1 101 1.8 
1997 1,076 7.5 429 5.0 640 11.3 157 1.1 75 0.9 81 1.4 
1998 1,012 7.6 366 4.8 644 11.4 127 1.0 52 0.7 74 1.3 
1999 865 7.2 271 4.1 590 11.1 127 1.1 38 0.6 88 1.7 
1. Isolates may be resistant to other drugs. 
2. Includes persons of unknown country of birth. 
3. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 

Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 

Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.

Note:  Data for all years updated through May 3, 2000.

More than 85% of all cases in each group had drug susceptibility test results reported for an initial isolate.

See Surveillance Slides #14 and #15.

Table 8. Resistance to Isoniazid with or without Rifampin Resistance in Reported TB Cases 
with Previous TB by Origin: United States, 1993-1999 
Resistant to Isoniazid1 Resistant to Isoniazid and Rifampin1 
Total Cases2 U. S.-born Foreign-born3 Total Cases2  U. S.-born  Foreign-born3 
Year No. % No. % No. % No. % No. % No. % 
1993 164 16.6 85 12.6 76 25.2 75 7.6 30 4.5 45 15.0 
1994 177 17.1 81 11.7 95 28.1 75 7.3 35 5.1 39 11.6 
1995 168 17.6 77 13.0 91 25.1 70 7.3 28 4.7 42 11.6 
1996 141 16.4 67 12.0 73 24.2 42 4.9 20 3.6 21 7.0 
1997 108 14.9 35 8.0 73 25.6 42 5.8 11 2.5 31 10.9 
1998 97 12.8 37 7.5 60 22.6 23 3.0 6 1.2 17 6.4 
1999 80 12.2 27 7.2 51 18.3 25 3.8 6 1.6 19 6.8 
1. Isolates may be resistant to other drugs. 
2. Includes persons of unknown country of birth. 
3. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 

Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 

Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.

Note:  Data for all years updated through May 3, 2000.

More than 85% of all cases in each group had drug susceptibility test results reported for an initial isolate.
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Table 9. Percentage of Reported TB Cases by Initial Drug Regimen, Use of Directly 
Observed Therapy, and Completion of Therapy (COT): United States, 1993-1999 
Directly Observed Therapy3 Therapy 
Initial Drug Regimen1 Both DOT and <1 Year Indicated4 
Year IR IRZ IRZ,E/S2 DOT Only Self-Administered COT <1 Year COT 
1993 13.0 31.2 40.9 21.7 14.4 63.5 87.5 
1994 7.0 23.3 56.3 28.1 20.5 68.4 87.8 
1995 5.2 20.3 63.4 37.2 21.4 72.8 89.5 
1996 4.1 17.5 67.9 42.4 22.4 75.5 90.2 
1997 3.2 15.1 72.4 46.9 23.7 77.2 90.0 
1998 2.6 12.9 74.6 … … … … 
1999 2.2 11.2 76.8 … … … … 
1. Includes cases in persons alive at diagnosis.

2. I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin. Excluding cases with no information on initial drug 

regimen, 1% were not started on any drugs, less than 1% were started on one drug, and approximately 10% had an initial multidrug 

regimen other than IR, IRZ, and IRZ,E/S.

3. Includes cases in persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.

4. Includes cases in persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during 

therapy. Excludes persons with initial isolate resistant to rifampin and pediatric (aged <15) cases with meningeal, bone or joint, or 

miliary disease. See Technical Notes (Appendix A) for description of COT calculation.

Ellipses indicate data not available.

Note:  Data for all years updated through May 3, 2000.

See Surveillance Slides #17 and #18. 

Table 10. Number and Percentage of Reported TB Cases with HIV Test 
Results and with HIV Coinfection by Age Group: United States, 1993-1998 
25-44 Years Old All Ages 
HIV HIV HIV HIV 
Test Results1 Positive2 Test Results1 Positive2 
Year No. % No. % No. % No. % 
1993 4,372 46 2,786 29 7,447 30 3,678 15 
1994 4,432 49 2,659 29 7,869 33 3,588 15 
1995 4,266 52 2,167 26 8,168 36 3,031 13 
1996 4,328 57 1,856 25 8,757 41 2,615 12 
1997 4,106 60 1,466 21 8,715 44 2,084 11 
1998 3,837 60 1,239 20 8,229 45 1,824 10 
1. Rhode Island reported HIV test results during 1998. HIV test results were not reported from California. California did 

provide HIV status for TB cases reported during 1993-1998 in persons also reported with AIDS (i.e., HIV-positive). 

Includes cases with positive, negative, or indeterminate HIV test results and California cases also reported with AIDS. 

Percentages based on all reported TB cases.

2. Includes cases with HIV-positive test results and California cases also reported with AIDS. Percentages based on all 

reported TB cases.

Note:  Data for all years updated through May 3, 2000.

See Surveillance Slide #16.
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Table 11. Tuberculosis Cases by Race/Ethnicity, Sex, and Age: United States, 1999 
Race/Ethnicity Age Group Not 
and Sex All Ages Under 5  5 - 14 15 - 24 25 - 44 45 - 64  65+ Stated 
Total Cases 17,531 605 439 1,516 6,078 4,862 4,028 3 
White, non-Hispanic 4,224 76 52 117 1,020 1,263 1,694 2 
Male 2,819 40 21 63 695 974 1,024 2 
Female 1,405 36 31 54 325 289 670 0 
Unknown 0 0 0 0 0 0 0 0 
Black, non-Hispanic 5,552 195 151 432 2,198 1,688 888 0 
Male 3,488 92 70 220 1,387 1,231 488 0 
Female 2,063 103 81 212 811 456 400 0 
Unknown 1 0 0 0 0 1 0 0 
Hispanic1 3,875 250 181 569 1,462 870 543 0 
Male 2,496 141 103 364 1,004 581 303 0 
Female 1,379 109 78 205 458 289 240 0 
Unknown 0 0 0 0 0 0 0 0 
American Indian/Alaskan Native 240 12 5 10 72 83 57 1 
Male 147 7 2 2 51 48 36 1 
Female 93 5 3 8 21 35 21 0 
Unknown 0 0 0 0 0 0 0 0 
Asian/Pacific Islander 3,591 70 49 385 1,307 947 833 0 
Male 1,966 37 26 177 667 535 524 0 
Female 1,625 33 23 208 640 412 309 0 
Unknown 0 0 0 0 0 0 0 0 
Not Stated 49 2 1 3 19 11 13 0 
Male 32 2 1 1 11 10 7 0 
Female 17 0 0 2 8 1 6 0 
Unknown 0 0 0 0 0 0 0 0 
1. Persons of Hispanic origin may be of any race. 
See Surveillance Slide #7. 
Table 12. Tuberculosis Case Rates per 100,000 Population by Race/Ethnicity, 
Sex, and Age: United States, 1999 
Race/Ethnicity Age Group 
and Sex All Ages Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+ 
Total Cases 6.4 3.2 1.1 4.0 7.3 8.2 11.7 
White, non-Hispanic 2.2 0.6 0.2 0.5 1.7 2.7 5.8 
Male 2.9 0.7 0.2 0.5 2.4 4.3 8.5 
Female 1.4 0.6 0.2 0.4 1.1 1.2 4.0 
Black, non-Hispanic 16.8 7.5 2.6 7.9 21.2 28.1 31.9 
Male 22.3 7.0 2.3 8.1 28.5 46.1 44.6 
Female 11.8 8.0 2.8 7.8 14.8 13.7 23.6 
Hispanic1 12.4 7.2 3.0 10.4 14.7 18.9 29.4 
Male 15.8 8.0 3.4 12.8 19.6 26.4 39.0 
Female 8.9 6.4 2.7 7.8 9.4 12.1 22.5 
American Indian/Alaskan Native 11.8 7.3 1.3 2.8 11.8 23.3 38.8 
Male 14.8 8.4 1.0 1.1 16.7 28.2 58.1 
Female 9.0 6.2 1.6 4.5 6.9 18.7 24.7 
Asian/Pacific Islander 35.3 8.4 3.1 26.0 37.5 46.5 108.2 
Male 40.3 8.7 3.2 23.9 40.8 56.4 161.7 
Female 30.6 8.0 3.0 28.1 34.5 37.9 69.3 
1. Persons of Hispanic origin may be of any race.
 
Note: Denominators for computing rates were obtained from National Population Estimates for the 1990's: Monthly 
 
Postcensal Resident Population, by Single Year of Age, Sex, Race, and Hispanic Origin 
 
(www.census.gov/population/estimates/nation/e90s/e9999rmp.txt). 

See Surveillance Slide #8. 
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Table 13. Tuberculosis Cases in U.S.-born Persons by Race/Ethnicity, Sex, and Age: United 
States, 1999 
Race/Ethnicity Age Group  Not 
and Sex All Ages Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+  Stated 
Total Cases 9,809 508 259 453 2,939 3,021 2,626 3 
White, non-Hispanic 3,637 65 38 68 841 1,116 1,507 2 
Male 2,490 33 17 35 597 875 931 2 
Female 1,147 32 21 33 244 241 576 0 
Unknown 0 0 0 0 0 0 0 0 
Black, non-Hispanic 4,593 183 106 238 1,692 1,529 845 0 
Male 2,943 87 52 124 1,077 1,135 468 0 
Female 1,649 96 54 114 615 393 377 0 
Unknown 1 0 0 0 0 1 0 0 
Hispanic1 1,127 202 94 101 292 267 171 0 
Male 697 118 54 59 185 188 93 0 
Female 430 84 40 42 107 79 78 0 
Unknown 0 0 0 0 0 0 0 0 
American Indian/Alaskan Native 234 12 4 9 70 83 55 1 
Male 144 7 2 2 50 48 34 1 
Female 90 5 2 7 20 35 21 0 
Unknown 0 0 0 0 0 0 0 0 
Asian/Pacific Islander 202 45 17 36 39 23 42 0 
Male 104 23 11 13 18 10 29 0 
Female 98 22 6 23 21 13 13 0 
Unknown 0 0 0 0 0 0 0 0 
Not Stated 16 1 0 1 5 3 6 0 
Male 12 1 0 1 3 3 4 0 
Female 4 0 0 0 2 0 2 0 
Unknown 0 0 0 0 0 0 0 0 
1. Persons of Hispanic origin may be of any race. 
Table 14. Tuberculosis Cases in Foreign-born Persons1 by Race/Ethnicity, Sex, and Age: 
United States, 1999 
Race/Ethnicity Age Group  Not 
and Sex All Ages Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+  Stated 
Total Cases 7,553 92 173 1,051 3,082 1,800 1,355 0 
White, non-Hispanic 560 11 14 49 174 139 173 0 
Male 310 7 4 28 94 92 85 0 
Female 250 4 10 21 80 47 88 0 
Unknown 0 0 0 0 0 0 0 0 
Black, non-Hispanic 916 11 42 192 485 150 36 0 
Male 519 5 16 94 297 88 19 0 
Female 397 6 26 98 188 62 17 0 
Unknown 0 0 0 0 0 0 0 0 
Hispanic2 2,704 47 84 462 1,157 594 360 0 
Male 1,766 22 49 301 806 386 202 0 
Female 938 25 35 161 351 208 158 0 
Unknown 0 0 0 0 0 0 0 0 
American Indian/Alaskan Native 6 0 1 1 2 0 2 0 
Male 3 0 0 0 1 0 2 0 
Female 3 0 1 1 1 0 0 0 
Unknown 0 0 0 0 0 0 0 0 
Asian/Pacific Islander 3,355 22 31 347 1,259 915 781 0 
Male 1,847 13 15 162 647 519 491 0 
Female 1,508 9 16 185 612 396 290 0 
Unknown 0 0 0 0 0 0 0 0 
Not Stated 12 1 1 0 5 2 3 0 
Male 7 1 1 0 2 2 1 0 
Female 5 0 0 0 3 0 2 0 
Unknown 0 0 0 0 0 0 0 0 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 
Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands. 
2. Persons of Hispanic origin may be of any race. 
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Table 15. Tuberculosis Cases and Case Rates per 100,000 Population: States, 1999 and 1998 
Rank According Population 
Cases  Case Rates to Rate Estimates 
State 1999 1998 1999 1998 1999 1998 July 1, 1999 
United States 17,531 18,361 6.4 6.8 272,691,000 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia1

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

314 381 7.2 8.8 11 6 4,369,000 
61 55 9.9 9.0 4 5 619,000 
262 254 5.5 5.4 19 21 4,778,000 
181 171 7.1 6.7 12 16 2,551,000 
3,606 3,852 10.9 11.8 2 2 33,145,000 
88 79 2.2 2.0 39 42 4,056,000 
121 128 3.7 3.9 31 30 3,282,000 
34 36 4.5 4.8 24 23 754,000 
70 107 13.5 20.5 519,000 
1,277 1,302 8.5 8.7 6 7 15,111,000 
665 631 8.5 8.3 5 9 7,788,000 
184 181 15.5 15.2 1 1 1,185,000 
16 14 1.3 1.1 46 47 1,252,000 
825 850 6.8 7.1 15 15 12,128,000 
150 188 2.5 3.2 37 34 5,943,000 
58 55 2.0 1.9 41 43 2,869,000 
69 56 2.6 2.1 36 39 2,654,000 
209 179 5.3 4.5 21 27 3,961,000 
357 380 8.2 8.7 8 8 4,372,000 
23 13 1.8 1.0 43 48 1,253,000 
294 324 5.7 6.3 18 19 5,172,000 
270 282 4.4 4.6 26 26 6,175,000 
351 385 3.6 3.9 33 28 9,864,000 
201 161 4.2 3.4 27 32 4,776,000 
215 225 7.8 8.2 10 10 2,769,000 
208 184 3.8 3.4 28 33 5,468,000 
14 20 1.6 2.3 44 38 883,000 
18 31 1.1 1.9 48 44 1,666,000 
93 128 5.1 7.3 22 14 1,809,000 
19 14 1.6 1.2 45 46 1,201,000 
571 640 7.0 7.9 13 12 8,143,000 
64 68 3.7 3.9 32 29 1,740,000 
1,837 2,000 10.1 11.0 3 3 18,197,000 
488 498 6.4 6.6 16 17 7,651,000 
7 10 1.1 1.6 47 45 634,000 
317 230 2.8 2.1 35 41 11,257,000 
208 198 6.2 5.9 17 20 3,358,000 
123 156 3.7 4.8 30 24 3,316,000 
454 448 3.8 3.7 29 31 11,994,000 
53 63 5.3 6.4 20 18 991,000 
315 286 8.1 7.5 9 13 3,886,000 
21 23 2.9 3.1 34 35 733,000 
382 439 7.0 8.1 14 11 5,484,000 
1,649 1,820 8.2 9.2 7 4 20,044,000 
40 52 1.9 2.5 42 36 2,130,000 
3 5 0.5 0.8 50 49 594,000 
334 339 4.9 5.0 23 22 6,873,000 
258 265 4.5 4.7 25 25 5,756,000 
41 42 2.3 2.3 38 37 1,807,000 
110 109 2.1 2.1 40 40 5,250,000 
3 4 0.6 0.8 49 50 480,000 
American Samoa1, 2 4 … 6.3 … 63,781 
Fed. States of Micronesia1, 2 ... ... ... ... 131,500 
Guam1, 2 69 89 45.4 59.7 151,968 
N. Mariana Islands1, 2 66 … 95.4 … 69,216 
Puerto Rico1, 2 200 201 5.1 5.2 3,889,507 
Republic of Palau1, 2 11 … 59.7 … 18,434 
U.S. Virgin Islands1, 2 ... ... ... ... 119,615 
1. Not ranked with the states.

2. Not included in U.S. totals.

Ellipses indicate data not available.

Note: Denominators for computing 1999 rates were obtained from State Population Estimates: Annual Time Series, July 1, 1990, to July 1, 1999, 

ST-99-3  (www.census.gov/population/estimates/state/st-99-3.txt). 

See Surveillance Slide #4.

21 
Table 16. Tuberculosis Cases by Age Group: States, 1999 
Total Unknown or 
State Cases Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+ Missing 
United States 17,531 605 439 1,516 6,078 4,862 4,028 3 
Alabama 314 8 1 13 80 102 110 0 
Alaska 61 0 2 4 26 13 16 0 
Arizona 262 7 2 26 99 59 69 0 
Arkansas 181 13 9 8 32 47 72 0 
California 3,606 153 116 334 1,161 975 867 0 
Colorado 88 9 4 5 26 22 22 0 
Connecticut 121 4 2 15 45 37 18 0 
Delaware 34 0 2 0 15 6 11 0 
District of Columbia 70 1 1 5 30 17 16 0 
Florida 1,277 33 17 70 516 416 225 0 
Georgia 665 38 22 67 251 191 96 0 
Hawaii 184 0 4 19 46 57 58 0 
Idaho 16 0 0 3 5 4 4 0 
Illinois 825 26 22 57 295 242 183 0 
Indiana 150 10 2 13 42 38 45 0 
Iowa 58 2 1 3 30 9 13 0 
Kansas 69 9 6 5 27 16 6 0 
Kentucky 209 2 3 7 58 60 78 1 
Louisiana 357 10 9 17 114 122 85 0 
Maine 23 0 0 0 5 7 11 0 
Maryland 294 8 6 32 109 71 68 0 
Massachusetts 270 5 4 35 114 62 50 0 
Michigan 351 14 10 22 112 99 94 0 
Minnesota 201 4 15 59 67 38 18 0 
Mississippi 215 12 7 12 45 62 77 0 
Missouri 208 9 9 7 66 46 71 0 
Montana 14 0 0 0 1 8 5 0 
Nebraska 18 0 0 2 8 5 3 0 
Nevada 93 3 2 8 25 36 17 2 
New Hampshire 19 1 0 2 8 2 6 0 
New Jersey 571 12 12 58 225 153 111 0 
New Mexico 64 1 1 7 18 11 26 0 
New York 1,837 43 49 163 814 476 292 0 
North Carolina 488 15 5 51 165 139 113 0 
North Dakota 7 0 0 1 0 3 3 0 
Ohio 317 6 2 25 80 85 119 0 
Oklahoma 208 14 7 20 70 54 43 0 
Oregon 123 5 4 13 38 34 29 0 
Pennsylvania 454 12 8 30 123 117 164 0 
Rhode Island 53 3 4 7 11 15 13 0 
South Carolina 315 7 6 19 107 101 75 0 
South Dakota 21 0 1 1 6 8 5 0 
Tennessee 382 16 4 21 118 102 121 0 
Texas 1,649 67 42 158 594 494 294 0 
Utah 40 1 2 3 10 13 11 0 
Vermont 3 0 0 0 0 2 1 0 
Virginia 334 9 4 40 114 79 88 0 
Washington 258 9 6 37 82 71 53 0 
West Virginia 41 0 0 0 3 17 21 0 
Wisconsin 110 4 4 12 40 18 32 0 
Wyoming 3 0 0 0 2 1 0 0 
American Samoa1 4 0 0 1 0 2 1 0 
Fed. States of Micronesia1 ... ... ... ... ... ... ... ... 
Guam1 69 0 1 4 21 36 7 0 
N. Mariana Islands1 66 2 0 9 37 18 0 0 
Puerto Rico1 200 3 1 14 67 68 47 0 
Republic of Palau1 11 1 0 1 4 5 0 0 
U.S. Virgin Islands1 ... ... ... ... ... ... ... ... 
1. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 17. Tuberculosis Cases by Race/Ethnicity: States, 1999 
American Indian Asian Unknown 
Total White, Black, or or or 
State Cases non-Hispanic non-Hispanic Hispanic1  Alaskan Native Pacific Islander Missing 
United States 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

17,531 4,224 5,552 3,875 240 3,591 49 
314 135 152 12 1 14 0 
61 5 0 2 41 13 0 
262 81 15 103 45 18 0 
181 85 61 20 1 13 1 
3,606 449 375 1,340 16 1,414 12 
88 26 13 29 1 19 0 
121 26 35 30 0 30 0 
34 11 12 2 0 9 0 
70 6 53 7 0 4 0 
1,277 374 620 209 1 72 1 
665 135 410 64 0 48 8 
184 9 1 5 0 165 4 
16 8 0 4 3 1 0 
825 188 349 140 0 143 5 
150 75 40 20 1 14 0 
58 25 5 12 1 15 0 
69 17 10 28 0 14 0 
209 150 38 13 0 8 0 
357 126 201 9 1 18 2 
23 16 2 0 0 5 0 
294 47 142 39 0 65 1 
270 75 74 35 0 86 0 
351 99 159 24 2 65 2 
201 26 95 18 7 55 0 
215 56 142 6 2 9 0 
208 81 92 8 2 24 1 
14 6 0 0 8 0 0 
18 7 2 4 1 4 0 
93 25 11 20 2 33 2 
19 11 1 1 0 5 1 
571 96 196 130 0 149 0 
64 8 0 31 24 1 0 
1,837 285 672 469 0 410 1 
488 112 270 64 3 38 1 
7 5 1 0 1 0 0 
317 131 136 19 1 29 1 
208 114 26 14 38 16 0 
123 44 9 26 3 41 0 
454 171 137 30 0 111 5 
53 16 11 12 0 14 0 
315 59 228 7 1 20 0 
21 4 1 1 14 1 0 
382 199 156 13 0 14 0 
1,649 338 403 742 1 165 0 
40 12 3 8 7 10 0 
3 2 0 0 0 1 0 
334 97 125 46 0 66 0 
258 81 33 42 10 91 1 
41 32 9 0 0 0 0 
110 37 26 15 1 31 0 
3 1 0 2 0 0 0 
American Samoa2 4 0 0 0 0 4 0 
Fed. States of Micronesia2 ... ... ... ... ... ... ... 
Guam2 69 0 0 0 0 64 5 
N. Mariana Islands2 66 0 0 1 0 63 2 
Puerto Rico2 200 0 0 199 0 0 1 
Republic of Palau2 
U.S. Virgin Islands2 
11 
... 
0 
... 
0 
... 
0 
... 
0 
... 
11 
... 
0 
... 
1. Persons of Hispanic origin may be of any race. 
2. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 18. Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons: States, 1999 
Total  U.S.-born Persons Foreign-born Persons1  Unknown 
State Cases No. % No. % No. % 
United States 17,531 9,809 56.0 7,553 43.1 169 1.0 
Alabama 314 287 91.4 26 8.3 1 0.3 
Alaska 61 46 75.4 14 23.0 1 1.6 
Arizona 262 154 58.8 107 40.8 1 0.4 
Arkansas 181 159 87.8 16 8.8 6 3.3 
California 3,606 1,074 29.8 2,503 69.4 29 0.8 
Colorado 88 41 46.6 47 53.4 0 0.0 
Connecticut 121 46 38.0 74 61.2 1 0.8 
Delaware 34 20 58.8 14 41.2 0 0.0 
District of Columbia 70 48 68.6 22 31.4 0 0.0 
Florida 1,277 834 65.3 442 34.6 1 0.1 
Georgia 665 520 78.2 136 20.5 9 1.4 
Hawaii 184 46 25.0 137 74.5 1 0.5 
Idaho 16 11 68.8 5 31.3 0 0.0 
Illinois 825 547 66.3 264 32.0 14 1.7 
Indiana 150 113 75.3 36 24.0 1 0.7 
Iowa 58 20 34.5 38 65.5 0 0.0 
Kansas 69 40 58.0 28 40.6 1 1.4 
Kentucky 209 188 90.0 21 10.0 0 0.0 
Louisiana 357 323 90.5 30 8.4 4 1.1 
Maine 23 16 69.6 7 30.4 0 0.0 
Maryland 294 140 47.6 154 52.4 0 0.0 
Massachusetts 270 83 30.7 187 69.3 0 0.0 
Michigan 351 251 71.5 99 28.2 1 0.3 
Minnesota 201 46 22.9 155 77.1 0 0.0 
Mississippi 215 202 94.0 13 6.0 0 0.0 
Missouri 208 169 81.3 38 18.3 1 0.5 
Montana 14 14 100.0 0 0.0 0 0.0 
Nebraska 18 9 50.0 9 50.0 0 0.0 
Nevada 93 40 43.0 52 55.9 1 1.1 
New Hampshire 19 12 63.2 7 36.8 0 0.0 
New Jersey 571 245 42.9 324 56.7 2 0.4 
New Mexico 64 45 70.3 19 29.7 0 0.0 
New York 1,837 774 42.1 988 53.8 75 4.1 
North Carolina 488 386 79.1 101 20.7 1 0.2 
North Dakota 7 6 85.7 1 14.3 0 0.0 
Ohio 317 241 76.0 74 23.3 2 0.6 
Oklahoma 208 176 84.6 32 15.4 0 0.0 
Oregon 123 52 42.3 71 57.7 0 0.0 
Pennsylvania 454 300 66.1 145 31.9 9 2.0 
Rhode Island 53 26 49.1 27 50.9 0 0.0 
South Carolina 315 292 92.7 23 7.3 0 0.0 
South Dakota 21 17 81.0 4 19.0 0 0.0 
Tennessee 382 341 89.3 41 10.7 0 0.0 
Texas 1,649 994 60.3 648 39.3 7 0.4 
Utah 40 21 52.5 19 47.5 0 0.0 
Vermont 3 2 66.7 1 33.3 0 0.0 
Virginia 334 179 53.6 155 46.4 0 0.0 
Washington 258 108 41.9 150 58.1 0 0.0 
West Virginia 41 41 100.0 0 0.0 0 0.0 
Wisconsin 110 62 56.4 48 43.6 0 0.0 
Wyoming 3 2 66.7 1 33.3 0 0.0 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 

Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 

Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.

See Surveillance Slide #10.
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Table 19. Tuberculosis Cases in Foreign-born Persons1 by Country of Origin: States, 1999 
Country of Origin 
Unknown 
Total Rep. Of Rep. Of All or 
State Cases Mexico Philippines Vietnam India China Haiti Korea Others2 Missing 
United States 7,553 1,753 913 721 557 366 284 220 2,736 3 
Alabama 26 5 2 3 3 0 0 2 11 0 
Alaska 14 1 8 0 1 0 0 2 2 0 
Arizona 107 67 9 3 5 0 0 0 23 0 
Arkansas 16 5 0 3 1 1 0 0 6 0 
California 2,503 820 487 346 90 142 2 81 533 2 
Colorado 47 14 0 7 7 0 0 0 19 0 
Connecticut 74 1 9 4 9 2 4 0 45 0 
Delaware 14 2 2 0 1 0 2 0 7 0 
District of Columbia 22 1 2 1 1 0 0 0 17 0 
Florida 442 45 20 18 16 8 142 5 188 0 
Georgia 136 32 2 17 13 3 0 4 65 0 
Hawaii 137 1 103 4 0 8 0 9 12 0 
Idaho 5 4 0 0 0 0 0 0 1 0 
Illinois 264 81 33 10 49 8 1 14 68 0 
Indiana 36 11 3 3 3 1 0 0 15 0 
Iowa 38 9 1 6 4 0 0 1 17 0 
Kansas 28 12 3 2 4 0 0 0 7 0 
Kentucky 21 8 2 1 5 0 0 0 5 0 
Louisiana 30 2 4 8 1 1 1 1 12 0 
Maine 7 0 0 3 1 0 0 0 3 0 
Maryland 154 7 13 11 15 3 5 16 84 0 
Massachusetts 187 2 3 28 18 15 18 1 102 0 
Michigan 99 6 9 8 27 12 0 4 33 0 
Minnesota 155 11 3 12 9 10 1 1 108 0 
Mississippi 13 2 5 1 2 0 0 0 3 0 
Missouri 38 3 4 5 4 4 0 2 16 0 
Montana 0 0 0 0 0 0 0 0 0 0 
Nebraska 9 2 0 2 0 0 0 1 4 0 
Nevada 52 14 28 2 1 0 0 0 7 0 
New Hampshire 7 0 1 1 2 0 0 0 3 0 
New Jersey 324 19 27 8 82 10 25 10 143 0 
New Mexico 19 17 0 0 1 0 0 0 1 0 
New York 988 47 38 18 62 101 74 28 620 0 
North Carolina 101 40 4 8 4 1 2 2 40 0 
North Dakota 1 0 0 0 0 0 0 0 1 0 
Ohio 74 4 0 6 8 3 1 3 48 1 
Oklahoma 32 7 1 4 4 1 0 0 15 0 
Oregon 71 21 6 14 4 1 0 1 24 0 
Pennsylvania 145 5 9 27 34 9 4 7 50 0 
Rhode Island 27 1 1 0 0 4 1 0 20 0 
South Carolina 23 2 2 3 7 1 0 2 6 0 
South Dakota 4 1 1 0 0 0 0 0 2 0 
Tennessee 41 8 4 5 5 0 0 0 19 0 
Texas 648 364 20 70 29 5 1 10 149 0 
Utah 19 5 1 3 0 1 0 0 9 0 
Vermont 1 0 0 0 0 0 0 0 1 0 
Virginia 155 5 18 17 10 3 0 8 94 0 
Washington 150 27 21 27 8 5 0 5 57 0 
West Virginia 0 0 0 0 0 0 0 0 0 0 
Wisconsin 48 11 4 2 7 3 0 0 21 0 
Wyoming 1 1 0 0 0 0 0 0 0 0 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying 
Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands. 
2. Includes 145 countries. 
See Surveillance Slide #11. 
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Table 20. Tuberculosis Cases in Foreign-born Persons1 by Number of Years in the United 
States: States, 1999
    Unknown or
       Total <1 Year  1 - 4  5 - 9  10 - 19 20+   Missing
State Cases No. % No. % No. % No. % No. % No. %
United States 7,553 1,450 19.2 1,552 20.5 1,088 14.4 1,305 17.3 966 12.8 1,192 15.8
Alabama 26 7 26.9 7 26.9 4 15.4 5 19.2 3 11.5 0 0.0
Alaska 14 1 7.1 1 7.1 0 0.0 0 0.0 0 0.0 12 85.7
Arizona 107 26 24.3 19 17.8 7 6.5 18 16.8 13 12.1 24 22.4
Arkansas 16 3 18.8 2 12.5 3 18.8 3 18.8 0 0.0 5 31.3
California 2,503 389 15.5 375 15.0 394 15.7 556 22.2 403 16.1 386 15.4
Colorado 47 15 31.9 15 31.9 8 17.0 6 12.8 3 6.4 0 0.0
Connecticut 74 7 9.5 24 32.4 15 20.3 13 17.6 12 16.2 3 4.1
Delaware 14 5 35.7 2 14.3 2 14.3 1 7.1 0 0.0 4 28.6
District of Columbia 22 5 22.7 7 31.8 4 18.2 3 13.6 1 4.5 2 9.1
Florida 442 89 20.1 86 19.5 60 13.6 87 19.7 44 10.0 76 17.2
Georgia 136 43 31.6 27 19.9 12 8.8 11 8.1 1 0.7 42 30.9
Hawaii 137 47 34.3 12 8.8 14 10.2 27 19.7 25 18.2 12 8.8
Idaho 5 0 0.0 1 20.0 1 20.0 0 0.0 1 20.0 2 40.0
Illinois 264 32 12.1 62 23.5 57 21.6 40 15.2 48 18.2 25 9.5
Indiana 36 8 22.2 8 22.2 4 11.1 2 5.6 1 2.8 13 36.1
Iowa 38 7 18.4 6 15.8 5 13.2 2 5.3 0 0.0 18 47.4
Kansas 28 3 10.7 10 35.7 7 25.0 3 10.7 4 14.3 1 3.6
Kentucky 21 9 42.9 4 19.0 3 14.3 2 9.5 1 4.8 2 9.5
Louisiana 30 5 16.7 6 20.0 2 6.7 4 13.3 4 13.3 9 30.0
Maine 7 0 0.0 1 14.3 3 42.9 1 14.3 1 14.3 1 14.3
Maryland 154 40 26.0 31 20.1 11 7.1 13 8.4 8 5.2 51 33.1
Massachusetts 187 42 22.5 51 27.3 36 19.3 37 19.8 14 7.5 7 3.7
Michigan 99 16 16.2 33 33.3 18 18.2 13 13.1 18 18.2 1 1.0
Minnesota 155 50 32.3 35 22.6 11 7.1 6 3.9 1 0.6 52 33.5
Mississippi 13 3 23.1 1 7.7 2 15.4 4 30.8 2 15.4 1 7.7
Missouri 38 9 23.7 10 26.3 6 15.8 3 7.9 5 13.2 5 13.2
Montana 0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Nebraska 9 0 0.0 3 33.3 1 11.1 1 11.1 0 0.0 4 44.4
Nevada 52 17 32.7 8 15.4 11 21.2 8 15.4 6 11.5 2 3.8
New Hampshire 7 2 28.6 2 28.6 0 0.0 0 0.0 0 0.0 3 42.9
New Jersey 324 63 19.4 75 23.1 38 11.7 36 11.1 19 5.9 93 28.7
New Mexico 19 10 52.6 2 10.5 1 5.3 3 15.8 3 15.8 0 0.0
New York 988 168 17.0 224 22.7 156 15.8 181 18.3 123 12.4 136 13.8
North Carolina 101 27 26.7 34 33.7 9 8.9 11 10.9 9 8.9 11 10.9
North Dakota 1 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Ohio 74 14 18.9 15 20.3 9 12.2 5 6.8 10 13.5 21 28.4
Oklahoma 32 3 9.4 4 12.5 4 12.5 1 3.1 3 9.4 17 53.1
Oregon 71 13 18.3 14 19.7 8 11.3 11 15.5 12 16.9 13 18.3
Pennsylvania 145 28 19.3 22 15.2 12 8.3 17 11.7 10 6.9 56 38.6
Rhode Island 27 4 14.8 2 7.4 2 7.4 3 11.1 1 3.7 15 55.6
South Carolina 23 11 47.8 2 8.7 4 17.4 3 13.0 0 0.0 3 13.0
South Dakota 4 0 0.0 3 75.0 1 25.0 0 0.0 0 0.0 0 0.0
Tennessee 41 10 24.4 12 29.3 3 7.3 3 7.3 3 7.3 10 24.4
Texas 648 109 16.8 165 25.5 100 15.4 130 20.1 137 21.1 7 1.1
Utah 19 2 10.5 2 10.5 3 15.8 3 15.8 2 10.5 7 36.8
Vermont 1 0 0.0 0 0.0 0 0.0 1 100.0 0 0.0 0 0.0
Virginia 155 58 37.4 91 58.7 5 3.2 0 0.0 0 0.0 1 0.6
Washington 150 33 22.0 26 17.3 26 17.3 21 14.0 11 7.3 33 22.0
West Virginia 0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Wisconsin 48 16 33.3 10 20.8 6 12.5 7 14.6 4 8.3 5 10.4
Wyoming 1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 100.0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying 
Islands, U.S. Miscellaneous  Pacific Islands, and the U.S. Virgin Islands.
See Surveillance Slide #13.
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Table 21. Tuberculosis Cases by Form of Disease: States, 1999 
Cases with Both Pulmonary 
and Extrapulmonary Disease 
Total Pulmonary1 Extrapulmonary2  'Total3 Miliary 
State Cases No. % No. %  No. % No. 
United States 17,531 12,761 72.8 3,438 19.6 1,322 7.5 321 
Alabama 314 257 81.8 42 13.4 15 4.8 0 
Alaska 61 51 83.6 7 11.5 3 4.9 0 
Arizona 262 215 82.1 27 10.3 20 7.6 6 
Arkansas 181 151 83.4 16 8.8 14 7.7 2 
California 3,606 2,629 72.9 721 20.0 253 7.0 67 
Colorado 88 54 61.4 23 26.1 11 12.5 4 
Connecticut 121 79 65.3 33 27.3 9 7.4 3 
Delaware 34 25 73.5 3 8.8 6 17.6 2 
District of Columbia 70 60 85.7 9 12.9 1 1.4 0 
Florida 1,277 1,005 78.7 203 15.9 69 5.4 18 
Georgia 665 508 76.4 113 17.0 43 6.5 9 
Hawaii 184 156 84.8 24 13.0 4 2.2 0 
Idaho 16 12 75.0 1 6.3 3 18.8 2 
Illinois 825 617 74.8 182 22.1 26 3.2 8 
Indiana 150 119 79.3 26 17.3 5 3.3 3 
Iowa 58 39 67.2 18 31.0 1 1.7 1 
Kansas 69 44 63.8 18 26.1 7 10.1 0 
Kentucky 209 176 84.2 25 12.0 8 3.8 2 
Louisiana 357 297 83.2 43 12.0 17 4.8 2 
Maine 23 14 60.9 9 39.1 0 0.0 0 
Maryland 294 196 66.7 67 22.8 31 10.5 17 
Massachusetts 270 150 55.6 89 33.0 31 11.5 15 
Michigan 351 234 66.7 83 23.6 33 9.4 3 
Minnesota 201 129 64.2 55 27.4 17 8.5 5 
Mississippi 215 176 81.9 35 16.3 4 1.9 0 
Missouri 208 157 75.5 37 17.8 14 6.7 2 
Montana 14 10 71.4 4 28.6 0 0.0 0 
Nebraska 18 11 61.1 7 38.9 0 0.0 0 
Nevada 93 77 82.8 15 16.1 1 1.1 0 
New Hampshire 19 14 73.7 3 15.8 2 10.5 0 
New Jersey 571 376 65.8 141 24.7 54 9.5 11 
New Mexico 64 46 71.9 7 10.9 11 17.2 1 
New York 1,837 1,235 67.2 373 20.3 228 12.4 45 
North Carolina 488 377 77.3 85 17.4 26 5.3 14 
North Dakota 7 3 42.9 3 42.9 1 14.3 0 
Ohio 317 216 68.1 81 25.6 19 6.0 8 
Oklahoma 208 157 75.5 39 18.8 12 5.8 3 
Oregon 123 80 65.0 32 26.0 11 8.9 4 
Pennsylvania 454 314 69.2 106 23.3 33 7.3 9 
Rhode Island 53 30 56.6 19 35.8 4 7.5 2 
South Carolina 315 203 64.4 67 21.3 45 14.3 16 
South Dakota 21 13 61.9 6 28.6 2 9.5 0 
Tennessee 382 279 73.0 60 15.7 43 11.3 7 
Texas 1,649 1,218 73.9 306 18.6 124 7.5 17 
Utah 40 23 57.5 12 30.0 5 12.5 1 
Vermont 3 1 33.3 1 33.3 1 33.3 1 
Virginia 334 252 75.4 71 21.3 11 3.3 2 
Washington 258 163 63.2 60 23.3 35 13.6 6 
West Virginia 41 34 82.9 5 12.2 1 2.4 1 
Wisconsin 110 77 70.0 26 23.6 7 6.4 1 
Wyoming 3 2 66.7 0 0.0 1 33.3 1 
American Samoa4 4 3 75.0 1 25.0 0 0.0 0 
Fed. States of Micronesia4 ... ... ... ... ... ... ... ... 
Guam4 69 64 92.8 3 4.3 2 2.9 2 
N. Mariana Islands4 66 55 83.3 5 7.6 6 9.1 1 
Puerto Rico4 200 172 86.0 22 11.0 6 3.0 2 
Republic of Palau4 11 9 81.8 2 18.2 0 0.0 0 
U.S. Virgin Islands4 ... ... ... ... ... ... ... ... 
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease.

2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site of 

disease.

3. Includes miliary cases.

4. Not included in U.S. totals.

Ellipses indicate data not available.

Note: 10 (0.1%) cases had missing and/or unknown site of disease.
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Table 22. Extrapulmonary Tuberculosis Cases by Site of Disease: States, 1999 
Total 
Extra-
pulmonary Bone and/ Genito-
State Cases Pleural Lymphatic or Joint urinary Meningeal Peritoneal Other 
United States 3,438 727 1,385 376 217 171 136 426 
Alabama 42 18 7 7 1 3 0 6 
Alaska 7 0 4 0 0 0 1 2 
Arizona 27 6 8 6 3 0 1 3 
Arkansas 16 8 6 0 1 0 0 1 
California 721 128 319 87 55 31 33 68 
Colorado 23 2 14 2 0 1 1 3 
Connecticut 33 5 12 4 3 3 3 3 
Delaware 3 1 0 0 2 0 0 0 
District of Columbia 9 0 5 2 1 0 0 1 
Florida 203 38 77 19 12 9 7 41 
Georgia 113 28 37 8 3 12 4 21 
Hawaii 24 4 6 4 4 1 0 5 
Idaho 1 0 0 0 0 0 0 1 
Illinois 182 46 64 25 12 8 6 21 
Indiana 26 9 8 0 1 3 0 5 
Iowa 18 5 7 2 3 0 0 1 
Kansas 18 3 6 1 0 1 2 5 
Kentucky 25 7 5 6 4 0 1 2 
Louisiana 43 11 14 5 2 1 2 8 
Maine 9 0 1 4 2 0 0 2 
Maryland 67 16 29 6 4 2 7 3 
Massachusetts 89 13 50 9 4 0 1 12 
Michigan 83 21 33 10 2 3 6 8 
Minnesota 55 10 26 7 0 2 4 6 
Mississippi 35 14 8 2 0 5 1 5 
Missouri 37 10 11 6 4 2 1 3 
Montana 4 2 0 1 0 0 0 1 
Nebraska 7 0 5 0 0 0 0 2 
Nevada 15 3 6 2 0 1 1 2 
New Hampshire 3 0 1 0 1 0 0 1 
New Jersey 141 17 76 21 8 2 4 13 
New Mexico 7 4 2 1 0 0 0 0 
New York 373 64 167 40 19 26 15 42 
North Carolina 85 30 19 10 5 7 3 11 
North Dakota 3 1 0 0 1 0 0 1 
Ohio 81 16 26 12 4 4 3 16 
Oklahoma 39 7 22 3 0 2 2 3 
Oregon 32 3 12 6 4 1 2 4 
Pennsylvania 106 21 47 9 11 3 3 12 
Rhode Island 19 1 11 0 0 0 0 7 
South Carolina 67 28 18 2 4 1 3 11 
South Dakota 6 1 0 0 1 2 2 0 
Tennessee 60 19 18 2 3 5 3 10 
Texas 306 73 117 29 19 23 9 36 
Utah 12 1 5 1 2 0 1 2 
Vermont 1 0 1 0 0 0 0 0 
Virginia 71 18 37 2 3 5 2 4 
Washington 60 12 29 8 2 1 2 6 
West Virginia 5 0 0 1 3 0 0 1 
Wisconsin 26 3 9 4 4 1 0 5 
Wyoming 0 0 0 0 0 0 0 0 
American Samoa1 1 0 1 0 0 0 0 0 
Fed. States of Micronesia1 ... ... ... ... ... ... ... ... 
Guam1 3 2 1 0 0 0 0 0 
N. Mariana Islands1 5 1 4 0 0 0 0 0 
Puerto Rico1 22 9 7 3 1 0 0 2 
Republic of Palau1 2 0 0 1 1 0 0 0 
U.S. Virgin Islands1 ... ... ... ... ... ... ... ... 
1. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 23. Tuberculosis Cases in Residents of Correctional Facilities: 59 Reporting Areas, 
1999 
Cases with Information on 
Total Residence in Correctional Facilities 
Reporting Area Cases No. % 
Percent of Cases in Residents 
of Correctional Facilities1 
United States 17,531 17,462 99.6 3.3 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York State2

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

314 314 100.0 2.2 
61 61 100.0 1.6 
262 262 100.0 6.9 
181 180 99.4 5.0 
3,606 3,597 99.8 3.3 
88 88 100.0 0.0 
121 120 99.2 1.7 
34 33 97.1 0.0 
70 70 100.0 4.3 
1,277 1,277 100.0 3.7 
665 652 98.0 3.2 
184 181 98.4 2.8 
16 16 100.0 6.3 
825 818 99.2 2.2 
150 147 98.0 1.4 
58 54 93.1 0.0 
69 68 98.6 1.5 
209 209 100.0 4.8 
357 355 99.4 2.5 
23 23 100.0 0.0 
294 294 100.0 2.7 
270 270 100.0 0.4 
351 351 100.0 2.3 
201 201 100.0 2.0 
215 215 100.0 1.4 
208 205 98.6 3.4 
14 14 100.0 0.0 
18 18 100.0 0.0 
93 92 98.9 5.4 
19 19 100.0 0.0 
571 571 100.0 1.2 
64 64 100.0 1.6 
377 376 99.7 5.9 
1,460 1,460 100.0 2.8 
488 488 100.0 2.3 
7 7 100.0 0.0 
317 315 99.4 2.2 
208 208 100.0 6.7 
123 122 99.2 0.8 
454 440 96.9 1.8 
53 52 98.1 1.9 
315 314 99.7 7.6 
21 21 100.0 0.0 
382 382 100.0 3.4 
1,649 1,649 100.0 6.2 
40 40 100.0 2.5 
3 3 100.0 0.0 
334 334 100.0 2.1 
258 258 100.0 1.6 
41 41 100.0 0.0 
110 110 100.0 2.7 
3 3 100.0 33.3 
American Samoa3 4 4 100.0 0.0 
Fed. States of Micronesia3 ... ... ... ... 
Guam3 69 69 100.0 1.4 
N. Mariana Islands3 66 66 100.0 1.5 
Puerto Rico3 200 200 100.0 6.5 
Republic of Palau3 
U.S. Virgin Islands3 
11 
... 
11 
... 
100.0 
... 
18.2 
... 
1. Resident of correctional facility at time of diagnosis. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 24. Tuberculosis Cases by Homeless Status: 59 Reporting Areas, 1999 
Cases with Information 
Total on Homeless Status 
Reporting Area Cases No. % Homeless Persons1 
Percent of Cases in 
United States 17,531 16,808 95.9 6.3 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York State2

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

314 312 99.4 3.8 
61 61 100.0 3.3 
262 258 98.5 14.0 
181 180 75.0 3.9 
3,606 3,554 98.6 6.6 
88 88 100.0 12.5 
121 119 98.3 9.2 
34 34 100.0 2.9 
70 70 100.0 14.3 
1,277 1,276 99.9 8.7 
665 632 95.0 7.0 
184 184 100.0 0.0 
16 15 93.8 6.7 
825 796 96.5 6.7 
150 133 88.7 3.0 
58 48 82.8 6.3 
69 64 92.8 1.6 
209 205 98.1 12.2 
357 350 98.0 5.7 
23 23 100.0 8.7 
294 293 99.7 3.1 
270 269 99.6 4.5 
351 342 97.4 3.5 
201 201 100.0 3.0 
215 215 100.0 1.4 
208 197 94.7 14.2 
14 14 100.0 35.7 
18 18 100.0 11.1 
93 92 98.9 8.7 
19 18 94.7 0.0 
571 571 100.0 5.3 
64 64 100.0 7.8 
377 372 98.7 1.9 
1,460 987 67.6 --
488 486 99.6 7.0 
7 6 85.7 16.7 
317 313 98.7 7.3 
208 208 100.0 11.1 
123 121 98.4 10.7 
454 423 93.2 2.1 
53 52 98.1 0.0 
315 314 99.7 3.8 
21 21 100.0 14.3 
382 376 98.4 7.4 
1,649 1,649 100.0 6.6 
40 40 100.0 17.5 
3 3 100.0 0.0 
334 334 100.0 2.7 
258 257 99.6 6.2 
41 37 90.2 13.5 
110 110 100.0 4.5 
3 3 100.0 0.0 
American Samoa3 4 4 100.0 0.0 
Fed. States of Micronesia3 ... ... ... ... 
Guam3 69 69 100.0 0.0 
N. Mariana Islands3 66 66 100.0 0.0 
Puerto Rico3 200 200 100.0 3.0 
Republic of Palau3 11 11 100.0 0.0 
U.S. Virgin Islands3 ... ... ... ... 
1. Homeless within past 12 months. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 25. Tuberculosis Cases in Residents of Long-term Care Facilities: 59 Reporting Areas, 1999
            Cases with Information on 
      Total  Residence in Long-term Care Facilities Percent of Cases in Residents
Reporting Area Cases No. %  of Long-term Care Facilities1
United States 17,531 17,466 99.6 3.0  
Alabama 314 314 100.0 5.4
Alaska 61 61 100.0 0.0
Arizona 262 262 100.0 2.7
Arkansas 181 179 98.9 8.9
California 3,606 3,599 99.8 2.1
Colorado 88 88 100.0 3.4
Connecticut 121 120 99.2 2.5
Delaware 34 34 100.0 2.9
District of Columbia 70 70 100.0 4.3
Florida 1,277 1,277 100.0 2.0
Georgia 665 651 97.9 2.5
Hawaii 184 184 100.0 1.1
Idaho 16 16 100.0 6.3
Illinois 825 816 98.9 4.4
Indiana 150 149 99.3 2.7
Iowa 58 52 89.7 1.9
Kansas 69 68 98.6 5.9
Kentucky 209 209 100.0 9.1
Louisiana 357 355 99.4 2.8
Maine 23 23 100.0 17.4
Maryland 294 293 99.7 2.4
Massachusetts 270 270 100.0 3.7
Michigan 351 351 100.0 2.6
Minnesota 201 201 100.0 1.0
Mississippi 215 215 100.0 3.7
Missouri 208 205 98.6 8.8
Montana 14 14 100.0 7.1
Nebraska 18 18 100.0 5.6
Nevada 93 92 98.9 0.0
New Hampshire 19 19 100.0 5.3
New Jersey 571 571 100.0 2.1
New Mexico 64 64 100.0 3.1
New York State2 377 377 100.0 4.2
New York City 1,460 1,458 99.9 1.4
North Carolina 488 488 100.0 4.9
North Dakota 7 7 100.0 14.3
Ohio 317 315 99.4 5.7
Oklahoma 208 208 100.0 2.4
Oregon 123 122 99.2 9.0
Pennsylvania 454 445 98.0 6.1
Rhode Island 53 52 98.1 1.9
South Carolina 315 314 99.7 2.5
South Dakota 21 21 100.0 9.5
Tennessee 382 381 99.7 3.4
Texas 1,649 1,649 100.0 2.5
Utah 40 40 100.0 2.5
Vermont 3 3 100.0 0.0
Virginia 334 334 100.0 1.8
Washington 258 258 100.0 3.1
West Virginia 41 41 100.0 0.0
Wisconsin 110 110 100.0 4.5
Wyoming 3 3 100.0 0.0
American Samoa3 4 4 100.0 0.0
Fed. States of Micronesia3 ... ... ... ...
Guam3 69 69 100.0 0.0
N. Mariana Islands3 66 66 100.0 0.0
Puerto Rico3 200 200 100.0 3.0
Republic of Palau3 11 11 100.0 0.0
U.S. Virgin Islands3 ... ... ... ...
1. Resident of long-term care facility at time of diagnosis.  Percentage for U.S. based on 52 reporting areas (50 states, New York   
City, and the District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.  
2. Excludes New York City.
3. Not included in U.S. totals.
Ellipses indicate data not available.
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Table 26. Tuberculosis Cases by Injecting Drug Use: 59 Reporting Areas, 1999 
Cases with Information on 
Total  Injecting Drug Use
Reporting Area Cases No. %
 Percent of Cases in 
Injecting Drug Users1 
United States 17,531 16,331 93.2 2.6 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York State2

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

314 280 89.2 1.8 
61 50 82.0 0.0 
262 251 95.8 4.0 
181 176 97.2 0.0 
3,606 3,438 95.3 2.7 
88 87 98.9 1.1 
121 112 92.6 3.6 
34 34 100.0 0.0 
70 67 95.7 6.0 
1,277 1,218 95.4 1.7 
665 517 77.7 1.4 
184 165 89.7 0.6 
16 14 87.5 0.0 
825 648 78.5 4.5 
150 138 92.0 2.9 
58 25 43.1 --
69 60 87.0 3.3 
209 199 95.2 1.5 
357 325 91.0 5.8 
23 22 95.7 0.0 
294 285 96.9 3.9 
270 237 87.8 2.5 
351 331 94.3 1.8 
201 200 99.5 1.0 
215 215 100.0 0.5 
208 192 92.3 3.1 
14 14 100.0 14.3 
18 18 100.0 0.0 
93 92 98.9 1.1 
19 18 94.7 0.0 
571 567 99.3 5.3 
64 60 93.8 0.0 
377 356 94.4 0.8 
1,460 1,320 90.4 3.2 
488 482 98.8 0.4 
7 5 71.4 --
317 293 92.4 1.7 
208 206 99.0 5.8 
123 117 95.1 1.7 
454 370 81.5 5.7 
53 52 98.1 1.9 
315 285 90.5 0.7 
21 21 100.0 0.0 
382 370 96.9 1.9 
1,649 1,632 99.0 3.1 
40 39 97.5 5.1 
3 1 33.3 --
334 334 100.0 0.3 
258 253 98.1 1.6 
41 30 73.2 --
110 108 98.2 2.8 
3 2 66.7 --
American Samoa3 4 4 100.0 0.0 
Fed. States of Micronesia3 ... ... ... ... 
Guam3 69 67 97.1 0.0 
N. Mariana Islands3 66 66 100.0 0.0 
Puerto Rico3 200 198 99.0 19.2 
Republic of Palau3 11 7 63.6 --
U.S. Virgin Islands3 ... ... ... ... 
1. Injecting drug use within past 12 months. Percentage for U.S. based on 52 reporting areas (50 states, New York City, 
and the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 27. Tuberculosis Cases by Noninjecting Drug Use: 59 Reporting Areas, 1999 
Cases with Information on 
Total Noninjecting Drug Use Percent of Cases in 
Reporting Area Cases No. %  Noninjecting Drug Users1 
United States 17,531 16,232 92.6 7.1 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York State2

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

314 275 87.6 5.1 
61 50 82.0 12.0 
262 250 95.4 8.0 
181 176 97.2 0.6 
3,606 3,425 95.0 6.7 
88 87 98.9 5.7 
121 109 90.1 6.4 
34 33 97.1 0.0 
70 67 95.7 11.9 
1,277 1,218 95.4 12.2 
665 514 77.3 11.3 
184 164 89.1 0.0 
16 13 81.3 7.7 
825 635 77.0 10.2 
150 136 90.7 3.7 
58 23 39.7 --
69 63 91.3 9.5 
209 198 94.7 7.6 
357 323 90.5 13.0 
23 22 95.7 0.0 
294 280 95.2 6.1 
270 233 86.3 3.9 
351 329 93.7 4.6 
201 199 99.0 3.5 
215 214 99.5 5.6 
208 192 92.3 9.9 
14 14 100.0 21.4 
18 18 100.0 0.0 
93 91 97.8 1.1 
19 18 94.7 0.0 
571 566 99.1 7.4 
64 60 93.8 0.0 
377 352 93.4 4.3 
1,460 1,318 90.3 8.7 
488 473 96.9 10.6 
7 5 71.4 --
317 289 91.2 7.3 
208 205 98.6 4.9 
123 113 91.9 6.2 
454 359 79.1 5.8 
53 52 98.1 5.8 
315 283 89.8 8.5 
21 21 100.0 0.0 
382 370 96.9 8.6 
1,649 1,632 99.0 5.0 
40 39 97.5 7.7 
3 1 33.3 --
334 334 100.0 0.9 
258 250 96.9 2.8 
41 31 75.6 3.2 
110 108 98.2 4.6 
3 2 66.7 --
American Samoa3 4 4 100.0 0.0 
Fed. States of Micronesia3 ... ... ... ... 
Guam3 69 65 94.2 1.5 
N. Mariana Islands3 66 66 100.0 0.0 
Puerto Rico3 200 198 99.0 16.2 
Republic of Palau3 11 8 72.7 --
U.S. Virgin Islands3 ... ... ... ... 
1. Noninjecting drug use within past 12 months. Percentage for U.S. based on 52 reporting areas (50 states, New York 
City, and the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of 
cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 28. Tuberculosis Cases by Excess Alcohol Use: 59 Reporting Areas, 1999 
Cases with Information on 
Total  Excess Alcohol Use  Percent of Cases in Persons 
Reporting Area Cases No. % with Excess Alcohol Use1 
United States 17,531 16,328 93.1 15.5 
Alabama 314 278 88.5 18.3 
Alaska 61 55 90.2 43.6 
Arizona 262 252 96.2 21.0 
Arkansas 181 177 97.8 10.2 
California 3,606 3,433 95.2 12.2 
Colorado 88 88 100.0 8.0 
Connecticut 121 110 90.9 13.6 
Delaware 34 33 97.1 9.1 
District of Columbia 70 67 95.7 19.4 
Florida 1,277 1,218 95.4 24.3 
Georgia 665 532 80.0 19.4 
Hawaii 184 172 93.5 6.4 
Idaho 16 16 100.0 37.5 
Illinois 825 636 77.1 20.6 
Indiana 150 140 93.3 3.6 
Iowa 58 27 46.6 --
Kansas 69 63 91.3 17.5 
Kentucky 209 201 96.2 18.9 
Louisiana 357 320 89.6 27.8 
Maine 23 22 95.7 0.0 
Maryland 294 284 96.6 8.5 
Massachusetts 270 232 85.9 7.8 
Michigan 351 326 92.9 8.3 
Minnesota 201 198 98.5 9.1 
Mississippi 215 215 100.0 25.6 
Missouri 208 191 91.8 20.9 
Montana 14 14 100.0 42.9 
Nebraska 18 18 100.0 5.6 
Nevada 93 92 98.9 8.7 
New Hampshire 19 19 100.0 10.5 
New Jersey 571 568 99.5 14.1 
New Mexico 64 60 93.8 16.7 
New York State2 377 353 93.6 8.2 
New York City 1,460 1,321 90.5 12.3 
North Carolina 488 475 97.3 27.2 
North Dakota 7 5 71.4 --
Ohio 317 295 93.1 15.6 
Oklahoma 208 206 99.0 14.6 
Oregon 123 114 92.7 15.8 
Pennsylvania 454 363 80.0 13.8 
Rhode Island 53 52 98.1 7.7 
South Carolina 315 287 91.1 27.9 
South Dakota 21 21 100.0 38.1 
Tennessee 382 366 95.8 18.3 
Texas 1,649 1,636 99.2 15.3 
Utah 40 39 97.5 20.5 
Vermont 3 2 66.7 --
Virginia 334 334 100.0 3.6 
Washington 258 253 98.1 7.5 
West Virginia 41 37 90.2 29.7 
Wisconsin 110 110 100.0 13.6 
Wyoming 3 2 66.7 --
American Samoa3 4 3 75.0 0.0 
Fed. States of Micronesia3 ... ... ... ... 
Guam3 69 64 92.8 3.1 
N. Mariana Islands3 66 65 98.5 13.8 
Puerto Rico3 200 198 99.0 15.7 
Republic of Palau3 11 7 63.6 --
U.S. Virgin Islands3 ... ... ... ... 
1. Excess alcohol use within past 12 months. Percentage for U.S. based on 52 reporting areas (50 states, New York City, 
and the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 29. Tuberculosis Cases by Initial Drug Regimen: 59 Reporting Areas, 1999 
Cases Cases with Information on 
Total Alive at Initial Drug Regimen  Percent of Cases with Initial Drug Regimen1 
Reporting Area Cases Diagnosis No. % IR IRZ  IRZ,E/S2 
United States 17,531 16,998 16,919 99.5 2.2 11.2 76.8 
Alabama 314 301 301 100.0 2.7 70.1 23.3 
Alaska 61 60 60 100.0 0.0 5.0 90.0 
Arizona 262 250 250 100.0 0.0 9.6 79.2 
Arkansas 181 175 171 97.7 43.9 37.4 14.6 
California 3,606 3,513 3,506 99.8 1.3 6.2 85.1 
Colorado 88 86 85 98.8 0.0 1.2 92.9 
Connecticut 121 120 120 100.0 0.8 14.2 80.0 
Delaware 34 34 34 100.0 0.0 8.8 88.2 
District of Columbia 70 68 68 100.0 0.0 4.4 85.3 
Florida 1,277 1,232 1,232 100.0 1.4 8.5 79.6 
Georgia 665 646 642 99.4 0.9 13.6 77.1 
Hawaii 184 178 176 98.9 7.4 16.5 71.0 
Idaho 16 16 16 100.0 0.0 25.0 75.0 
Illinois 825 808 797 98.6 1.5 7.7 73.4 
Indiana 150 146 146 100.0 2.7 19.9 63.7 
Iowa 58 57 57 100.0 1.8 21.1 66.7 
Kansas 69 65 63 96.9 4.8 22.2 61.9 
Kentucky 209 200 200 100.0 1.0 11.0 77.0 
Louisiana 357 343 332 96.8 2.4 14.5 77.4 
Maine 23 23 23 100.0 4.3 17.4 73.9 
Maryland 294 286 286 100.0 1.0 6.6 87.8 
Massachusetts 270 264 264 100.0 0.8 6.1 84.1 
Michigan 351 337 337 100.0 5.0 32.9 51.6 
Minnesota 201 198 198 100.0 0.5 16.7 71.7 
Mississippi 215 208 207 99.5 1.4 16.4 79.7 
Missouri 208 202 201 99.5 2.0 8.5 72.6 
Montana 14 13 13 100.0 0.0 15.4 84.6 
Nebraska 18 18 18 100.0 11.1 5.6 61.1 
Nevada 93 92 92 100.0 1.1 5.4 87.0 
New Hampshire 19 18 18 100.0 0.0 22.2 77.8 
New Jersey 571 548 548 100.0 2.0 9.3 73.9 
New Mexico 64 57 57 100.0 1.8 33.3 61.4 
New York State3 377 364 364 100.0 1.6 8.0 81.3 
New York City 1,460 1,426 1,426 100.0 1.1 3.6 81.6 
North Carolina 488 477 476 99.8 0.4 3.8 89.3 
North Dakota 7 7 7 100.0 14.3 14.3 71.4 
Ohio 317 305 304 99.7 5.9 22.7 56.9 
Oklahoma 208 199 199 100.0 8.5 17.1 58.8 
Oregon 123 122 118 96.7 0.8 4.2 90.7 
Pennsylvania 454 432 417 96.5 2.6 9.4 78.4 
Rhode Island 53 53 52 98.1 3.8 1.9 84.6 
South Carolina 315 302 302 100.0 1.0 16.2 64.2 
South Dakota 21 19 19 100.0 0.0 10.5 78.9 
Tennessee 382 371 371 100.0 2.4 19.4 68.5 
Texas 1,649 1,598 1,586 99.2 1.8 10.2 77.7 
Utah 40 36 36 100.0 5.6 16.7 69.4 
Vermont 3 3 3 100.0 0.0 0.0 66.7 
Virginia 334 324 324 100.0 1.2 14.8 77.5 
Washington 258 250 250 100.0 1.6 6.0 89.6 
West Virginia 41 39 39 100.0 10.3 35.9 35.9 
Wisconsin 110 106 105 99.1 3.8 9.5 75.2 
Wyoming 3 3 3 100.0 0.0 0.0 66.7 
American Samoa4 4 4 4 100.0 0.0 0.0 100.0 
Fed. States of Micronesia4 ... ... ... ... ... ... ... 
Guam4 69 67 67 100.0 0.0 0.0 86.6 
N. Mariana Islands4 66 64 64 100.0 0.0 4.7 90.6 
Puerto Rico4 200 181 181 100.0 0.0 1.7 93.4 
Republic of Palau4 11 11 11 100.0 9.1 9.1 63.6 
U.S. Virgin Islands4 ... ... ... ... ... ... ... 
1. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for 

reporting areas with information reported for >75% of cases.

2. I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.

3. Excludes New York City.

4. Not included in U.S. totals.

Ellipses indicate data not available.

Note:  Excluding cases with no information on initial drug regimen, 159 (0.9%) were not started on any drugs, 27 (0.2%) were started on 

one drug, and 1,463 (8.6%) had an initial multidrug regimen other than IR, IRZ, and IRZ,E/S.
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Table 30. Isoniazid-Resistant Tuberculosis Cases with or without Rifampin Resistance: 
59 Reporting Areas, 1999 
Total Cases with Initial 
Culture Drug Susceptibility Resistance1 
Positive Testing Performed Isoniazid Isoniazid and Rifampin 
Reporting Area Cases No. % No. % No. % 
United States 13,997 12,869 91.9 962 7.5 154 1.2 
Alabama 268 252 94.0 2 0.8 0 0.0 
Alaska 59 59 100.0 1 1.7 0 0.0 
Arizona 231 224 97.0 9 4.0 2 0.9 
Arkansas 136 131 96.3 8 6.1 0 0.0 
California 2,733 2,585 94.6 276 10.7 33 1.3 
Colorado 71 71 100.0 5 7.0 0 0.0 
Connecticut 110 104 94.5 6 5.8 2 1.9 
Delaware 26 23 88.5 1 4.3 0 0.0 
District of Columbia 65 50 76.9 3 6.0 1 2.0 
Florida 1,141 1,006 88.2 109 10.8 12 1.2 
Georgia 504 384 76.2 28 7.3 4 1.0 
Hawaii 141 136 96.5 12 8.8 2 1.5 
Idaho 15 11 73.3 -- -- -- --
Illinois 689 630 91.4 31 4.9 9 1.4 
Indiana 118 112 94.9 5 4.5 1 0.9 
Iowa 40 30 75.0 2 6.7 1 3.3 
Kansas 59 55 93.2 3 5.5 0 0.0 
Kentucky 189 164 86.8 8 4.9 2 1.2 
Louisiana 293 259 88.4 6 2.3 0 0.0 
Maine 20 17 85.0 0 0.0 0 0.0 
Maryland 231 213 92.2 15 7.0 3 1.4 
Massachusetts 227 222 97.8 15 6.8 0 0.0 
Michigan 275 274 99.6 19 6.9 7 2.6 
Minnesota 167 160 95.8 19 11.9 4 2.5 
Mississippi 160 158 98.8 6 3.8 0 0.0 
Missouri 163 154 94.5 5 3.2 2 1.3 
Montana 14 14 100.0 0 0.0 0 0.0 
Nebraska 18 18 100.0 3 16.7 0 0.0 
Nevada 67 65 97.0 3 4.6 0 0.0 
New Hampshire 17 15 88.2 0 0.0 0 0.0 
New Jersey 446 436 97.8 45 10.3 6 1.4 
New Mexico 59 57 96.6 4 7.0 0 0.0 
New York State2 263 257 97.7 15 5.8 1 0.4 
New York City 1,145 1,042 91.0 101 9.7 34 3.3 
North Carolina 398 382 96.0 23 6.0 3 0.8 
North Dakota 3 0 0.0 -- -- -- --
Ohio 239 211 88.3 14 6.6 2 1.0 
Oklahoma 163 152 93.3 2 1.3 0 0.0 
Oregon 95 88 92.6 8 9.1 0 0.0 
Pennsylvania 362 314 86.7 27 8.6 4 1.3 
Rhode Island 36 27 75.0 3 11.1 1 3.7 
South Carolina 233 188 80.7 5 2.7 0 0.0 
South Dakota 19 18 94.7 0 0.0 0 0.0 
Tennessee 304 297 97.7 11 3.7 0 0.0 
Texas 1,340 1,201 89.6 61 5.1 10 0.8 
Utah 29 29 100.0 1 3.4 0 0.0 
Vermont 3 3 100.0 0 0.0 0 0.0 
Virginia 271 243 89.7 15 6.2 4 1.6 
Washington 208 198 95.2 19 9.6 2 1.0 
West Virginia 39 37 94.9 2 5.4 0 0.0 
Wisconsin 94 92 97.9 6 6.5 2 2.2 
Wyoming 1 1 100.0 0 0.0 0 0.0 
American Samoa3 3 1 33.3 -- -- -- --
Fed. States of Micronesia3 ... ... ... ... ... ... ... 
Guam3 45 38 84.4 1 2.6 0 0.0 
N. Mariana Islands3 32 31 96.9 6 19.4 0 0.0 
Puerto Rico3 179 175 97.8 3 1.7 1 0.6 
Republic of Palau3 7 7 100.0 2 28.6 2 28.6 
U.S. Virgin Islands3 ... ... ... ... ... ... ... 
1. Isolates may be resistant to other drugs. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 31. Tuberculosis Cases, Aged 25 - 44, by HIV Status: 59 Reporting Areas, 1999 
Cases with Information 
Total on HIV Status1
Reporting Area Cases No. % HIV-Positive Persons2 
Percent of Cases in 
United States 6,078 3,475 57.2 
Alabama 80 73 91.3 11.0

Alaska 26 15 57.7

Arizona 99 83 83.8 12.0

Arkansas 32 25 78.1 8.0

California 1,161 … … …

Colorado 26 23 88.5 8.7

Connecticut 45 32 71.1

Delaware 15 11 73.3

District of Columbia 30 30 100.0 43.3

Florida 516 444 86.0 44.1

Georgia 251 193 76.9 35.8

Hawaii 46 3 6.5

Idaho 5 4 80.0 0.0

Illinois 295 110 37.3

Indiana 42 13 31.0

Iowa 30 12 40.0

Kansas 27 18 66.7

Kentucky 58 42 72.4

Louisiana 114 101 88.6 24.8

Maine 5 0 0.0

Maryland 109 89 81.7 21.3

Massachusetts 114 58 50.9

Michigan 112 39 34.8

Minnesota 67 44 65.7

Mississippi 45 44 97.8 6.8

Missouri 66 55 83.3 10.9

Montana 1 1 100.0 0.0

Nebraska 8 2 25.0

Nevada 25 25 100.0 16.0

New Hampshire 8 5 62.5

New Jersey 225 126 56.0 
New Mexico 18 12 66.7 
New York State3 143 84 58.7 
New York City 671 506 75.4 42.5 
North Carolina 165 149 90.3 24.2 
North Dakota 0 0 0.0

Ohio 80 49 61.3

Oklahoma 70 29 41.4

Oregon 38 32 84.2 12.5

Pennsylvania 123 57 46.3

Rhode Island 11 3 27.3

South Carolina 107 100 93.5 35.0

South Dakota 6 5 83.3 0.0

Tennessee 118 94 79.7 25.5

Texas 594 448 75.4 30.1

Utah 10 10 100.0 30.0

Vermont 0 0 0.0

Virginia 114 81 71.1

Washington 82 57 69.5

West Virginia 3 3 100.0 0.0

Wisconsin 40 34 85.0 5.9

Wyoming 2 2 100.0 0.0

American Samoa4 0 0 0.0 
Fed. States of Micronesia4 ... ... ... ... 
Guam4 21 4 19.0 
N. Mariana Islands4 37 35 94.6 2.9 
Puerto Rico4 67 54 80.6 77.8 
Republic of Palau4 4 2 50.0 
U.S. Virgin Islands4 ... ... ... ... 
1. Includes only those cases with negative, positive, and indeterminate HIV test results. 
2. Percentages shown only for reporting areas with information reported for >75% of cases. 
3. Excludes New York City. 
4. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 32. Tuberculosis Cases by Occupation: 59 Reporting Areas, 1999 
Cases with Percent of Cases by Occupation1 
Information Unemployed Health 
Total on Occupation Past Care Correctional Migrant Other Multiple 
Reporting Area Cases No. % 24 Mos.  Worker Employee Worker Occupation Occupations 
United States 17,531 16,223 92.5 58.2 2.6 0.1 1.1 37.8 0.2 
Alabama 314 308 98.1 64.0 2.6 0.0 0.3 33.1 0.0 
Alaska 61 34 55.7 -- -- -- -- -- --
Arizona 262 253 96.6 59.7 0.4 0.0 2.0 37.9 0.0 
Arkansas 181 168 92.8 75.6 3.6 0.6 0.0 20.2 0.0 
California 3,606 3,430 95.1 59.4 2.1 0.2 1.8 36.5 0.1 
Colorado 88 88 100.0 62.5 2.3 0.0 0.0 35.2 0.0 
Connecticut 121 107 88.4 52.3 4.7 0.0 0.0 43.0 0.0 
Delaware 34 33 97.1 48.5 3.0 0.0 6.1 42.4 0.0 
District of Columbia 70 70 100.0 81.4 0.0 0.0 0.0 18.6 0.0 
Florida 1,277 1,245 97.5 48.9 2.1 0.2 3.3 45.1 0.5 
Georgia 665 554 83.3 52.3 1.4 0.4 1.8 44.0 0.0 
Hawaii 184 171 92.9 65.5 1.2 0.6 0.6 32.2 0.0 
Idaho 16 16 100.0 62.5 0.0 0.0 12.5 25.0 0.0 
Illinois 825 706 85.6 58.8 3.7 0.1 0.7 36.5 0.1 
Indiana 150 115 76.7 56.5 4.3 0.0 0.0 39.1 0.0 
Iowa 58 40 69.0 -- -- -- -- -- --
Kansas 69 53 76.8 58.5 1.9 0.0 0.0 39.6 0.0 
Kentucky 209 202 96.7 63.4 3.0 0.0 3.5 30.2 0.0 
Louisiana 357 329 92.2 59.3 2.7 0.0 0.0 38.0 0.0 
Maine 23 23 100.0 65.2 4.3 0.0 0.0 30.4 0.0 
Maryland 294 281 95.6 56.6 3.6 0.0 0.0 39.9 0.0 
Massachusetts 270 254 94.1 53.5 3.1 0.0 0.0 43.3 0.0 
Michigan 351 234 66.7 -- -- -- -- -- --
Minnesota 201 196 97.5 59.2 5.1 0.0 1.0 34.7 0.0 
Mississippi 215 213 99.1 66.2 1.4 0.5 0.9 30.5 0.5 
Missouri 208 190 91.3 61.1 3.7 0.0 0.0 35.3 0.0 
Montana 14 14 100.0 71.4 0.0 0.0 0.0 28.6 0.0 
Nebraska 18 18 100.0 38.9 0.0 0.0 0.0 61.1 0.0 
Nevada 93 90 96.8 63.3 0.0 0.0 0.0 36.7 0.0 
New Hampshire 19 19 100.0 42.1 5.3 0.0 0.0 52.6 0.0 
New Jersey 571 570 99.8 60.2 2.5 0.0 0.5 36.3 0.5 
New Mexico 64 59 92.2 55.9 1.7 0.0 1.7 40.7 0.0 
New York State2 377 348 92.3 57.5 4.0 0.3 0.6 37.4 0.3 
New York City 1,460 1,289 88.3 65.6 2.9 0.2 0.0 31.3 0.1 
North Carolina 488 473 96.9 51.8 2.7 0.4 1.7 42.9 0.4 
North Dakota 7 5 71.4 -- -- -- -- -- --
Ohio 317 298 94.0 64.4 3.4 0.3 0.7 31.2 0.0 
Oklahoma 208 205 98.6 50.7 2.0 0.5 0.0 46.8 0.0 
Oregon 123 116 94.3 52.6 6.0 0.0 3.4 37.1 0.9 
Pennsylvania 454 371 81.7 67.4 4.6 0.0 0.0 28.0 0.0 
Rhode Island 53 52 98.1 71.2 3.8 0.0 0.0 25.0 0.0 
South Carolina 315 292 92.7 59.9 1.4 0.0 1.7 36.3 0.7 
South Dakota 21 21 100.0 71.4 9.5 0.0 0.0 19.0 0.0 
Tennessee 382 358 93.7 63.7 2.0 0.0 0.0 34.4 0.0 
Texas 1,649 1,538 93.3 59.8 2.1 0.1 0.7 37.1 0.2 
Utah 40 40 100.0 67.5 2.5 0.0 0.0 30.0 0.0 
Vermont 3 3 100.0 33.3 0.0 0.0 0.0 66.7 0.0 
Virginia 334 334 100.0 36.8 3.6 0.0 0.0 59.3 0.3 
Washington 258 246 95.3 22.8 2.0 0.0 2.0 72.8 0.4 
West Virginia 41 41 100.0 87.8 0.0 0.0 0.0 12.2 0.0 
Wisconsin 110 108 98.2 48.1 2.8 0.0 0.9 48.1 0.0 
Wyoming 3 2 66.7 -- -- -- -- -- --
American Samoa3 4 3 75.0 66.7 0.0 0.0 0.0 33.3 0.0 
Fed. States of Micronesia3 ... ... ... ... ... ... ... ... ... 
Guam3 69 45 65.2 -- -- -- -- -- --
N. Mariana Islands3 66 66 100.0 12.1 0.0 0.0 0.0 87.9 0.0 
Puerto Rico3 200 199 99.5 86.9 1.0 1.0 0.0 11.1 0.0 
Republic of Palau3 
U.S. Virgin Islands3 
11 
... 
8 72.7 
... ... ... 
--
... ... ... ... 
-- -- -- --
... 
--
1. Occupation within past 24 months. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 33. Tuberculosis Cases by Type of Health Care Provider: 59 Reporting Areas, 1997 
Percent of Cases by Type of Health Care Provider1 
Cases  Cases with Information on 
Total Alive at Type of Health Care Provider Health Health Department 
Reporting Area Cases Diagnosis No. % Department Private/Other and Private/Other 
Both 
United States 19,753 19,078 18,739 98.2 43.8 27.0 29.2 
Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York State2

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

405 388 388 100.0 59.0 7.5 33.5 
78 75 75 100.0 18.7 4.0 77.3 
296 284 283 99.6 53.7 29.3 17.0 
200 191 180 94.2 56.1 1.1 42.8 
4,044 3,942 3,924 99.5 51.4 30.4 18.2 
93 90 89 98.9 61.8 18.0 20.2 
128 121 121 100.0 15.7 84.3 0.0 
39 37 37 100.0 59.5 16.2 24.3 
110 107 106 99.1 52.8 34.0 13.2 
1,392 1,328 1,308 98.5 47.3 17.7 35.0 
695 678 665 98.1 41.4 18.3 40.3 
165 161 161 100.0 48.4 18.6 32.9 
15 15 13 86.7 23.1 23.1 53.8 
966 933 905 97.0 37.8 50.2 12.0 
168 161 160 99.4 6.3 15.6 78.1 
74 73 67 91.8 49.3 11.9 38.8 
78 76 76 100.0 59.2 10.5 30.3 
184 176 174 98.9 40.2 16.1 43.7 
406 385 321 83.4 35.8 14.3 49.8 
21 21 21 100.0 42.9 23.8 33.3 
339 331 325 98.2 64.6 15.7 19.7 
268 264 260 98.5 48.1 24.2 27.7 
372 358 357 99.7 54.3 31.9 13.7 
161 159 159 100.0 50.3 47.2 2.5 
245 239 239 100.0 5.0 2.9 92.1 
248 237 230 97.0 19.6 18.7 61.7 
18 18 18 100.0 72.2 0.0 27.8 
22 21 21 100.0 0.0 90.5 9.5 
112 106 97 91.5 72.2 10.3 17.5 
17 17 17 100.0 0.0 5.9 94.1 
718 705 689 97.7 56.0 40.3 3.6 
72 70 70 100.0 47.1 15.7 37.1 
526 506 481 95.1 46.4 31.2 22.5 
1,704 1,648 1,646 99.9 33.5 24.1 42.3 
463 448 442 98.7 34.2 11.1 54.8 
12 12 12 100.0 0.0 16.7 83.3 
286 270 269 99.6 46.5 33.1 20.4 
211 204 196 96.1 94.4 5.6 0.0 
161 159 157 98.7 42.0 29.3 28.7 
524 500 471 94.2 42.0 24.8 33.1 
40 39 38 97.4 81.6 15.8 2.6 
328 315 298 94.6 75.5 5.4 19.1 
19 18 18 100.0 83.3 0.0 16.7 
468 442 440 99.5 30.0 13.9 56.1 
1,980 1,906 1,888 99.1 30.0 42.8 27.1 
36 34 33 97.1 39.4 0.0 60.6 
6 6 6 100.0 0.0 0.0 100.0 
349 332 320 96.4 48.8 37.8 13.4 
305 293 290 99.0 45.2 18.6 36.2 
54 49 49 100.0 16.3 44.9 38.8 
130 128 127 99.2 4.7 5.5 89.8 
2 2 2 100.0 0.0 50.0 50.0 
American Samoa3 ... ... ... ... ... ... ... 
Fed. States of Micronesia3 ... ... ... ... ... ... ... 
Guam3 ... ... ... ... ... ... ... 
N. Mariana Islands3 94 94 91 96.8 98.9 1.1 0.0 
Puerto Rico3 257 231 229 99.1 94.8 4.8 0.4 
Republic of Palau3 
U.S. Virgin Islands3 
17 
... 
17 
... 
15 
... 
88.2 
... 
80.0 
... 
6.7 
... 
13.3 
... 
1. Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact investigation and 
dispensing of medication) provided by non-health department providers; Both Health Department and Private/Other:Both sectors involved in the care of the 
patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for reporting 
areas with information reported for >75% of cases. 
2. Excludes New York City. 
3. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 34. Tuberculosis Cases by Directly Observed Therapy: 59 Reporting Areas, 1997 
Cases with Initial Cases with Information on 
Percent of Cases by 
Administration of Therapy2 
Reporting Area 
Total Drug Regimen 
Cases Prescribed1 
Directly Observed Therapy 
No. %
DOT  Both DOT and 
Only  Self-Administered 
United States 19,753 18,927 18,397 97.2 46.9 23.7 
Alabama 405 388 388 100.0 81.7 15.2 
Alaska 78 75 75 100.0 78.7 13.3 
Arizona 296 279 277 99.3 58.1 12.3 
Arkansas 200 187 179 95.7 43.0 15.1 
California 4,044 3,902 3,766 96.5 43.4 19.4 
Colorado 93 90 88 97.8 72.7 17.0 
Connecticut 128 121 121 100.0 57.0 3.3 
Delaware 39 37 37 100.0 45.9 24.3 
District of Columbia 110 106 106 100.0 36.8 24.5 
Florida 1,392 1,316 1,289 97.9 42.1 37.9 
Georgia 695 678 660 97.3 51.4 32.3 
Hawaii 165 161 161 100.0 58.4 13.0 
Idaho 15 15 13 86.7 53.8 38.5 
Illinois 966 907 881 97.1 45.5 11.8 
Indiana 168 160 160 100.0 40.6 8.8 
Iowa 74 73 68 93.2 39.7 23.5 
Kansas 78 76 76 100.0 76.3 14.5 
Kentucky 184 174 172 98.9 49.4 29.7 
Louisiana 406 378 316 83.6 57.9 28.8 
Maine 21 21 21 100.0 52.4 4.8 
Maryland 339 330 329 99.7 87.2 3.6 
Massachusetts 268 264 260 98.5 34.2 15.0 
Michigan 372 352 352 100.0 11.9 18.2 
Minnesota 161 159 151 95.0 42.4 26.5 
Mississippi 245 239 238 99.6 99.6 0.4 
Missouri 248 237 236 99.6 59.3 20.8 
Montana 18 18 18 100.0 55.6 22.2 
Nebraska 22 21 21 100.0 14.3 9.5 
Nevada 112 101 93 92.1 25.8 12.9 
New Hampshire 17 17 17 100.0 11.8 29.4 
New Jersey 718 703 689 98.0 11.5 43.4 
New Mexico 72 70 70 100.0 38.6 25.7 
New York State3 526 505 502 99.4 66.5 15.7 
New York City 1,704 1,632 1,627 99.7 1.7 61.6 
North Carolina 463 445 438 98.4 70.8 18.5 
North Dakota 12 12 12 100.0 66.7 8.3 
Ohio 286 270 270 100.0 57.4 15.2 
Oklahoma 211 203 195 96.1 63.6 1.5 
Oregon 161 158 158 100.0 60.1 19.6 
Pennsylvania 524 498 469 94.2 47.8 15.4 
Rhode Island 40 39 38 97.4 100.0 0.0 
South Carolina 328 315 297 94.3 80.5 7.7 
South Dakota 19 18 18 100.0 55.6 5.6 
Tennessee 468 442 425 96.2 26.8 38.8 
Texas 1,980 1,899 1,795 94.5 69.9 17.1 
Utah 36 34 33 97.1 63.6 12.1 
Vermont 6 6 6 100.0 33.3 16.7 
Virginia 349 326 319 97.9 53.3 6.6 
Washington 305 292 290 99.3 62.8 12.4 
West Virginia 54 48 47 97.9 14.9 8.5 
Wisconsin 130 128 128 100.0 53.9 10.2 
Wyoming 2 2 2 100.0 0.0 0.0 
American Samoa4 ... ... ... ... ... ... 
Fed. States of Micronesia4 ... ... ... ... ... ... 
Guam4 ... ... ... ... ... ... 
N. Mariana Islands4 94 92 89 96.7 97.8 1.1 
Puerto Rico4 257 230 228 99.1 46.9 5.3 
Republic of Palau4 
U.S. Virgin Islands4 
17 
... 
17 
... 
15 
... 
88.2 
... 
33.3 
... 
60.0 
... 
1. Includes patients alive at diagnosis with an initial drug regimen of one or more drugs prescribed. 
2. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown 
only for reporting areas with information reported for >75% of cases. 
3. Excludes New York City. 
4. Not included in U.S. totals. 
Ellipses indicate data not available. 
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Table 35. Completion of Tuberculosis Therapy (COT): 59 Reporting Areas, 1997 
Therapy >1 Year Indicated2 Overall 
Reporting Area Cases No.3 COT <1 Year(%) COT(%) No.3 COT(%) No.3 COT(%) 
United States 19,753 16,884 77.2 90.0 297 73.7 17,181 89.7 
Alabama 405 338 82.5 94.1 4 75.0 342 93.9 
Alaska 78 72 91.7 98.6 0 ... 72 98.6 
Arizona 296 245 75.5 88.6 6 66.7 251 88.0 
Arkansas 200 170 86.5 91.8 1 100.0 171 91.8 
California 4,044 3,559 76.5 90.8 64 79.7 3,623 90.6 
Colorado 93 78 84.6 89.7 4 75.0 82 89.0 
Connecticut 128 110 89.1 95.5 1 100.0 111 95.5 
Delaware 39 34 85.3 91.2 0 ... 34 91.2 
District of Columbia 110 88 65.9 85.2 2 50.0 90 84.4 
Florida 1,392 1,152 77.7 90.7 22 86.4 1,174 90.6 
Georgia 695 597 78.9 93.6 12 66.7 609 93.1 
Hawaii 165 146 89.7 93.8 0 ... 146 93.8 
Idaho 15 15 0 ... 15 
Illinois 966 806 76.8 88.7 21 81.0 827 88.5 
Indiana 168 138 82.6 88.4 0 ... 138 88.4 
Iowa 74 69 76.8 81.2 0 ... 69 81.2 
Kansas 78 67 71.6 79.1 1 100.0 68 79.4 
Kentucky 184 154 85.1 96.1 0 ... 154 96.1 
Louisiana 406 341 6 347 
Maine 21 19 78.9 84.2 0 ... 19 84.2 
Maryland 339 291 85.2 93.5 1 100.0 292 93.5 
Massachusetts 268 242 79.8 90.9 8 100.0 250 91.2 
Michigan 372 311 78.1 89.7 2 50.0 313 89.5 
Minnesota 161 146 85.6 95.9 2 100.0 148 95.9 
Mississippi 245 212 89.6 95.3 1 100.0 213 95.3 
Missouri 248 204 84.8 93.6 3 100.0 207 93.7 
Montana 18 17 88.2 100.0 0 ... 17 100.0 
Nebraska 22 17 64.7 76.5 0 ... 17 76.5 
Nevada 112 90 68.9 78.9 1 100.0 91 79.1 
New Hampshire 17 16 75.0 87.5 0 ... 16 87.5 
New Jersey 718 635 71.3 89.4 14 64.3 649 88.9 
New Mexico 72 64 87.5 98.4 0 ... 64 98.4 
New York State4 526 458 69.9 86.9 7 71.4 465 86.7 
New York City 1,704 1,403 74.3 86.8 50 40.0 1,453 85.2 
North Carolina 463 394 87.1 95.4 6 83.3 400 95.3 
North Dakota 12 7 85.7 100.0 0 ... 7 100.0 
Ohio 286 236 80.9 92.8 1 100.0 237 92.8 
Oklahoma 211 174 81.0 92.5 4 100.0 178 92.7 
Oregon 161 149 83.9 89.3 2 50.0 151 88.7 
Pennsylvania 524 431 74.7 89.3 3 66.7 434 89.2 
Rhode Island 40 36 83.3 91.7 0 ... 36 91.7 
South Carolina 328 275 62.5 86.2 1 100.0 276 86.2 
South Dakota 19 18 88.9 100.0 0 ... 18 100.0 
Tennessee 468 375 83.7 96.3 4 100.0 379 96.3 
Texas 1,980 1,711 75.2 89.1 32 84.4 1,743 89.0 
Utah 36 33 72.7 97.0 0 ... 33 97.0 
Vermont 6 5 80.0 100.0 0 ... 5 100.0 
Virginia 349 301 76.1 86.4 4 50.0 305 85.9 
Washington 305 272 82.4 90.8 5 80.0 277 90.6 
West Virginia 54 43 72.1 79.1 0 ... 43 79.1 
Wisconsin 130 118 86.4 97.5 2 100.0 120 97.5 
Wyoming 2 2 100.0 100.0 0 ... 2 100.0 
Total Therapy 1 Year Indicated1 <
American Samoa5 ... ... ...  ... ... ... ... ... 
Fed. States of Micronesia5 ... ... ... ... ... ... ... ... 
Guam5 ... ... ... ... ... ... ... ... 
N. Mariana Islands5 94 88 71.6 71.6 4 25.0 92 69.6 
Puerto Rico5 257 183 87.4 94.0 5 40.0 188 92.6 
Republic of Palau5 17 16 0 ... 16 
U.S. Virgin Islands5 ... ... ... ... ... ... ... ... 
1. Initial isolate susceptible to rifampin (n=12,776) or susceptibility unknown (n=4,802); culture-negative (n=2,673); culture status unknown (n=954); 

age unknown (n=1).

2. Initial isolate rifampin resistant, or pediatric (aged <15) case with meningeal, bone or joint, or miliary disease.

3. Number of cases in persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Percentage 

for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for reporting areas with 

information on reason therapy stopped for >90% of cases.

4. Excludes New York City.

5. Not included in U.S. totals. 

Ellipses indicate data not available.

Note: See Technical Notes (Appendix A) for description of COT calculation.
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Table 36. Tuberculosis Cases in Selected Cities: 1999 and 1998 
Cases1 
City 1999 1998 
Albuquerque, NM 13 16 
Anaheim, Calif 37 48 
Arlington, Tex 19 21 
Atlanta, Ga 112 129 
Austin, Tex 70 64 
Baltimore, Md 77 84 
Birmingham, Ala 51 65 
Boston, Mass 77 89 
Buffalo, NY 9 16 
Charlotte, NC 73 55 
Chicago, Ill 463 473 
Cincinnati, Ohio 20 14 
Cleveland, Ohio 78 45 
Colorado Springs, Colo 9 4 
Columbus, Ohio 52 40 
Corpus Christi, Tex 26 35 
Dallas, Tex 162 199 
Denver, Colo 39 33 
Detroit, Mich 134 142 
El Paso, Tex 60 74 
Fort Worth, Tex 74 86 
Fresno, Calif 77 87 
Honolulu, Hawaii 88 77 
Houston, Tex 416 424 
Indianapolis, Ind 35 41 
Jacksonville, Fla 89 101 
Kansas City, Mo 42 40 
Las Vegas, Nev 56 92 
Long Beach, Calif 88 57 
Los Angeles, Calif 504 544 
Louisville, Ky 30 35 
Memphis, Tenn 94 109 
Mesa, Ariz 9 10 
Miami, Fla 92 101 
Milwaukee, Wis 46 38 
Minneapolis, Minn 85 63 
Nashville, Tenn 50 70 
New Orleans, La 67 84 
New York, NY 1,460 1,558 
Newark, NJ 58 90 
Norfolk, Va 20 16 
Oakland, Calif 114 99 
Oklahoma City, Okla 53 43 
Omaha, Neb 4 12 
Philadelphia, Pa 182 179 
Phoenix, Ariz 96 93 
Pittsburgh, Pa 17 26 
Portland, Ore 53 70 
Sacramento, Calif 72 92 
St. Louis, Mo 41 61 
St. Paul, Minn 22 22 
San Antonio, Tex 91 87 
San Diego, Calif 162 194 
San Francisco, Calif 235 207 
San Jose, Calif 176 180 
Santa Ana, Calif 47 57 
Seattle, Wash 74 84 
Tampa, Fla 84 66 
Toledo, Ohio 6 7 
Tucson, Ariz 38 42 
Tulsa, Okla 37 27 
Virginia Beach, Va 15 8 
Washington, DC 70 107 
Wichita, Kan 25 20 
Total - 64 Cities 6,775 7,152 
San Juan, Puerto Rico 31 36 
1. Case counts are based on verified cases in persons residing within city limits. Residence within city 
limits was determined by the health department. 
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Table 37. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan
Statistical Areas with >500,000 Population, 1999 and 1998 
Population 
Metropolitan Cases Case Rates Estimates 
Statistical Area 1999 1998 1999 1998 1999 
Akron, Ohio 14 7 2.0 1.0 689,435 
Albany-Schenectady, NY 19 14 2.2 1.6 869,474 
Albuquerque, NM 16 25 2.4 3.7 678,820 
Allentown, Pa 17 22 2.7 3.6 618,350 
Ann Arbor, Mich 15 4 2.7 0.7 557,349 
Atlanta, Ga 343 334 8.9 8.9 3,857,097 
Austin, Tex 90 92 7.9 8.3 1,146,050 
Bakersfield, Calif 62 48 9.6 7.6 642,495 
Baltimore, Md 134 160 5.4 6.4 2,491,254 
Baton Rouge, La 39 27 6.7 4.7 578,946 
Bergen-Passaic, NJ 104 117 7.7 8.7 1,342,116 
Birmingham, Ala 77 89 8.4 9.8 915,077 
Boston, Mass 267 274 4.5 4.7 5,901,589 
Buffalo, NY 25 35 2.2 3.0 1,142,121 
Charleston, SC 28 37 5.1 6.8 552,803 
Charlotte, NC 103 107 7.3 7.7 1,417,217 
Chicago, Ill 717 730 9.0 9.2 8,008,507 
Cincinnati, Ohio 42 30 2.6 1.9 1,627,509 
Cleveland, Ohio 109 77 4.9 3.5 2,221,181 
Columbia, SC 30 25 5.8 4.9 516,251 
Columbus, Ohio 62 47 4.2 3.2 1,489,487 
Dallas, Tex 255 291 7.8 9.1 3,280,310 
Dayton, Ohio 16 17 1.7 1.8 958,698 
Denver, Colo 65 54 3.3 2.8 1,978,991 
Detroit, Mich 231 261 5.2 5.8 4,474,614 
El Paso, Tex 61 81 8.7 11.5 701,908 
Fort Lauderdale, Fla 143 135 9.3 9.0 1,535,468 
Fort Worth, Tex 117 117 7.2 7.3 1,629,213 
Fresno, Calif 110 121 12.5 13.9 879,829 
Gary, Ind 22 23 3.5 3.7 628,377 
Grand Rapids, Mich 32 32 3.0 3.1 1,052,092 
Greensboro, NC 68 65 5.8 5.6 1,179,384 
Greenville, SC 34 36 3.7 3.9 929,565 
Harrisburg, Pa 11 25 1.8 4.1 618,375 
Hartford, Conn 48 47 4.3 4.2 1,113,800 
Honolulu, Hawaii 147 149 17.0 17.1 864,571 
Houston, Tex 482 482 12.0 12.3 4,010,969 
Indianapolis, Ind 50 56 3.3 3.7 1,536,665 
Jacksonville, Fla 105 117 9.9 11.2 1,056,332 
Jersey City, NJ 84 88 15.2 15.8 552,819 
Kansas City, Mo 63 62 3.6 3.6 1,755,899 
Knoxville, Tenn 42 45 6.2 6.8 672,087 
Las Vegas, Nev 68 109 4.9 8.2 1,381,086 
Little Rock, Ark 24 20 4.3 3.6 559,078 
Los Angeles, Calif 1,265 1,372 13.6 14.9 9,329,989 
Louisville, Ky 47 51 4.7 5.1 1,005,849 
McAllen, Tex 75 80 14.0 15.3 534,907 
Memphis, Tenn 97 131 8.8 12.0 1,105,058 
Miami, Fla 273 288 12.5 13.4 2,175,634 
Middlesex, NJ 82 94 7.3 8.4 1,130,592 
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Table 37. (Cont'd) Tuberculosis Cases and Case Rates per 100,000 Population:
Metropolitan Statistical Areas with >500,000 Population, 1999 and 1998 
Population 
Metropolitan Cases Case Rates Estimates 
Statistical Area 1999 1998 1999 1998 1999 
Milwaukee, Wis

Minneapolis-St. Paul, Minn

Mobile, Ala

Monmouth-Ocean City, NJ

Nashville, Tenn

Nassau-Suffolk, NY

New Haven, Conn

New Orleans, La

New York, NY

Newark, NJ

Norfolk, Va

Oakland, Calif

Oklahoma City, Okla

Omaha, Neb

Orange County, Calif

Orlando, Fla

Philadelphia, Pa

Phoenix, Ariz

Pittsburgh, Pa

Portland, Ore

Providence, RI

Raleigh-Durham, NC

Richmond, Va

Riverside-San Bernardino, Calif

Rochester, NY

Sacramento, Calif

St. Louis, Mo

Salt Lake City, Utah

San Antonio, Tex

San Diego, Calif

San Francisco, Calif

San Jose, Calif

Sarasota, Fla

Scranton, Pa

Seattle, Wash

Springfield, Mass

Stockton, Calif

Syracuse, NY

Tacoma, Wash

Tampa-St. Petersburg, Fla

Toledo, Ohio

Tucson, Ariz

Tulsa, Okla

Vallejo, Calif

Ventura, Calif

Washington, DC

West Palm Beach, Fla

Wichita, Kan

Wilmington, Del

Youngstown, Ohio

59 54 4.0 3.7 1,462,422 
161 124 5.6 4.4 2,872,109 
34 43 6.3 8.1 535,472 
33 40 3.0 3.7 1,108,977 
85 97 7.3 8.4 1,171,755 
129 154 4.8 5.8 2,688,904 
65 76 4.0 4.7 1,634,542 
122 149 9.3 11.4 1,305,479 
1,540 1,657 17.7 19.1 8,712,600 
181 209 9.3 10.7 1,954,671 
62 65 4.0 4.2 1,562,635 
338 332 14.4 14.3 2,348,723 
79 77 7.6 7.4 1,046,283 
9 20 1.3 2.9 698,875 
245 298 8.9 10.9 2,760,948 
154 163 10.0 10.8 1,535,004 
299 286 6.0 5.8 4,949,867 
159 145 5.3 4.9 3,013,696 
62 52 2.7 2.2 2,331,336 
87 118 4.7 6.5 1,845,840 
52 61 5.7 6.7 907,795 
79 82 7.1 7.6 1,105,535 
28 37 2.9 3.9 961,416 
192 175 6.0 5.6 3,200,587 
30 44 2.8 4.1 1,079,073 
101 120 6.4 7.8 1,585,429 
98 110 3.8 4.3 2,569,029 
32 42 2.5 3.3 1,275,076 
100 98 6.4 6.4 1,564,949 
297 339 10.5 12.2 2,820,844 
307 307 18.2 18.2 1,685,647 
244 251 14.8 15.3 1,647,419 
19 35 3.5 6.4 550,077 
23 14 3.8 2.3 611,492 
127 136 5.4 5.9 2,334,934 
12 12 2.0 2.0 589,171 
74 65 13.1 11.8 563,183 
37 23 5.0 3.1 732,920 
43 36 6.2 5.3 688,807 
156 152 6.8 6.7 2,278,169 
10 8 1.6 1.3 608,976 
46 51 5.7 6.4 803,618 
46 34 5.9 4.4 786,117 
35 ... 6.9 ... 506,685 
62 57 8.3 7.8 745,063 
366 398 7.7 8.5 4,739,999 
108 83 10.3 8.0 1,049,420 
29 22 5.3 4.0 548,714 
15 12 2.6 2.1 571,420 
10 17 1.7 2.9 589,236 
Total - 100 Areas 13,111 13,730 7.7 8.1 171,136,225 
San Juan, Puerto Rico 79 79 3.9 3.9 2,018,359 
Note:  In 1999, there were 100 metropolitan statistical areas with populations of 500,000 or more. In 1998, Vallejo, California, metropolitan 

statistical area had a population under 500,000.

Ellipses indicate data not applicable.
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Table 38. Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas with 
>500,000 Population, 1999 
Cases with Both Pulmonary 
and Extrapulmonary Disease 
Metropolitan Total Pulmonary1 Extrapulmonary2 Total3 Miliary 
Statistical Area Cases No. % No. % No. % No. 
Akron, Ohio 14 10 71.4 4 28.6 0 0.0 0 
Albany-Schenectady, NY 19 9 47.4 7 36.8 3 15.8 0 
Albuquerque, NM 16 15 93.8 1 6.3 0 0.0 0 
Allentown, Pa 17 16 94.1 1 5.9 0 0.0 0 
Ann Arbor, Mich 15 11 73.3 3 20.0 0 0.0 0 
Atlanta, Ga 343 249 72.6 71 20.7 23 6.7 6 
Austin, Tex 90 66 73.3 17 18.9 7 7.8 0 
Bakersfield, Calif 62 46 74.2 12 19.4 4 6.5 2 
Baltimore, Md 134 92 68.7 31 23.1 11 8.2 4 
Baton Rouge, La 39 29 74.4 8 20.5 2 5.1 0 
Bergen-Passaic, NJ 104 60 57.7 35 33.7 9 8.7 1 
Birmingham, Ala 77 65 84.4 12 15.6 0 0.0 0 
Boston, Mass 267 147 55.1 89 33.3 31 11.6 15 
Buffalo, NY 25 15 60.0 4 16.0 6 24.0 0 
Charleston, SC 28 16 57.1 7 25.0 5 17.9 0 
Charlotte, NC 103 82 79.6 17 16.5 4 3.9 2 
Chicago, Ill 717 535 74.6 163 22.7 19 2.6 7 
Cincinnati, Ohio 42 34 81.0 5 11.9 3 7.1 1 
Cleveland, Ohio 109 63 57.8 33 30.3 13 11.9 7 
Columbia, SC 30 21 70.0 7 23.3 2 6.7 0 
Columbus, Ohio 62 48 77.4 13 21.0 0 0.0 0 
Dallas, Tex 255 187 73.3 44 17.3 24 9.4 2 
Dayton, Ohio 16 10 62.5 5 31.3 1 6.3 0 
Denver, Colo 65 37 56.9 17 26.2 11 16.9 4 
Detroit, Mich 231 153 66.2 54 23.4 24 10.4 2 
El Paso, Tex 61 34 55.7 22 36.1 5 8.2 1 
Fort Lauderdale, Fla 143 101 70.6 34 23.8 8 5.6 0 
Fort Worth, Tex 117 88 75.2 21 17.9 8 6.8 1 
Fresno, Calif 110 89 80.9 12 10.9 9 8.2 0 
Gary, Ind 22 15 68.2 6 27.3 1 4.5 1 
Grand Rapids, Mich 32 19 59.4 9 28.1 4 12.5 1 
Greensboro, NC 68 52 76.5 11 16.2 5 7.4 3 
Greenville, SC 34 27 79.4 3 8.8 4 11.8 3 
Harrisburg, Pa 11 8 72.7 3 27.3 0 0.0 0 
Hartford, Conn 48 34 70.8 12 25.0 2 4.2 1 
Honolulu, Hawaii 147 126 85.7 18 12.2 3 2.0 0 
Houston, Tex 482 326 67.6 118 24.5 38 7.9 4 
Indianapolis, Ind 50 40 80.0 7 14.0 3 6.0 2 
Jacksonville, Fla 105 90 85.7 13 12.4 2 1.9 1 
Jersey City, NJ 84 62 73.8 14 16.7 8 9.5 1 
Kansas City, Mo 63 41 65.1 18 28.6 4 6.3 0 
Knoxville, Tenn 42 29 69.0 8 19.0 5 11.9 1 
Las Vegas, Nev 68 54 79.4 13 19.1 1 1.5 0 
Little Rock, Ark 24 18 75.0 4 16.7 2 8.3 0 
Los Angeles, Calif 1,265 902 71.3 253 20.0 110 8.7 28 
Louisville, Ky 47 39 83.0 8 17.0 0 0.0 0 
McAllen, Tex 75 64 85.3 8 10.7 3 4.0 1 
Memphis, Tenn 97 68 70.1 14 14.4 15 15.5 3 
Miami, Fla 273 216 79.1 44 16.1 13 4.8 8 
Middlesex, NJ 82 51 62.2 27 32.9 4 4.9 0 
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease. 
2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site of 
disease. 
3. Includes miliary cases. 
50 
Table 38. (Cont'd) Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas
with >500,000 Population, 1999 
Cases with Both Pulmonary 
Metropolitan Total Pulmonary1 Extrapulmonary2 
and Extrapulmonary Disease 
Total3 Miliary 
Statistical Area Cases No. % No. % No. % No. 
Milwaukee, Wis 59 35 59.3 20 33.9 4 6.8 1 
Minneapolis-St. Paul, Minn 161 100 62.1 46 28.6 15 9.3 5 
Mobile, Ala 34 26 76.5 5 14.7 3 8.8 0 
Monmouth-Ocean City, NJ 33 21 63.6 7 21.2 5 15.2 2 
Nashville, Tenn 85 57 67.1 17 20.0 11 12.9 1 
Nassau-Suffolk, NY 129 99 76.7 24 18.6 6 4.7 0 
New Haven, Conn 65 40 61.5 19 29.2 6 9.2 2 
New Orleans, La 122 100 82.0 12 9.8 10 8.2 2 
New York, NY 1,540 1,036 67.3 302 19.6 201 13.1 44 
Newark, NJ 181 126 69.6 35 19.3 20 11.0 5 
Norfolk, Va 62 51 82.3 8 12.9 3 4.8 0 
Oakland, Calif 338 261 77.2 57 16.9 20 5.9 7 
Oklahoma City, Okla 79 61 77.2 13 16.5 5 6.3 2 
Omaha, Neb 9 5 55.6 4 44.4 0 0.0 0 
Orange County, Calif 245 168 68.6 55 22.4 22 9.0 5 
Orlando, Fla 154 121 78.6 21 13.6 12 7.8 1 
Philadelphia, Pa 299 193 64.5 80 26.8 25 8.4 6 
Phoenix, Ariz 159 139 87.4 13 8.2 7 4.4 1 
Pittsburgh, Pa 62 39 62.9 16 25.8 7 11.3 2 
Portland, Ore 87 58 66.7 23 26.4 6 6.9 1 
Providence, RI 52 29 55.8 19 36.5 4 7.7 2 
Raleigh-Durham, NC 79 57 72.2 16 20.3 6 7.6 3 
Richmond, Va 28 19 67.9 8 28.6 1 3.6 0 
Riverside-San Bernardino, Calif 192 155 80.7 30 15.6 7 3.6 3 
Rochester, NY 30 15 50.0 10 33.3 5 16.7 0 
Sacramento, Calif 101 80 79.2 16 15.8 5 5.0 1 
St. Louis, Mo 98 77 78.6 13 13.3 8 8.2 1 
Salt Lake City, Utah 32 20 62.5 8 25.0 4 12.5 1 
San Antonio, Tex 100 79 79.0 10 10.0 10 10.0 1 
San Diego, Calif 297 195 65.7 75 25.3 27 9.1 5 
San Francisco, Calif 307 238 77.5 50 16.3 18 5.9 5 
San Jose, Calif 244 159 65.2 77 31.6 8 3.3 5 
Sarasota, Fla 19 17 89.5 1 5.3 1 5.3 1 
Scranton, Pa 23 17 73.9 4 17.4 2 8.7 0 
Seattle, Wash 127 66 52.0 36 28.3 25 19.7 5 
Springfield, Mass 12 10 83.3 2 16.7 0 0.0 0 
Stockton, Calif 74 57 77.0 12 16.2 5 6.8 3 
Syracuse, NY 37 27 73.0 7 18.9 3 8.1 1 
Tacoma, Wash 43 28 65.1 11 25.6 4 9.3 0 
Tampa-St. Petersburg, Fla 156 121 77.6 29 18.6 6 3.8 2 
Toledo, Ohio 10 6 60.0 1 10.0 3 30.0 0 
Tucson, Ariz 46 36 78.3 7 15.2 3 6.5 0 
Tulsa, Okla 46 32 69.6 10 21.7 4 8.7 1 
Vallejo, Calif 35 29 82.9 4 11.4 2 5.7 0 
Ventura, Calif 62 44 71.0 15 24.2 3 4.8 0 
Washington, DC 366 257 70.2 83 22.7 26 7.1 13 
West Palm Beach, Fla 108 79 73.1 22 20.4 7 6.5 1 
Wichita, Kan 29 21 72.4 7 24.1 1 3.4 0 
Wilmington, Del 15 10 66.7 2 13.3 3 20.0 2 
Youngstown, Ohio 10 4 40.0 6 60.0 0 0.0 0 
Total - 100 Areas 13,111 9,329 71.2 2,728 20.8 1,048 8.0 256 
San Juan, Puerto Rico 79 68 86.1 9 11.4 2 2.5 1 
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease.
 
2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site of 
 
disease.
 
3. Includes miliary cases.
 
Note: 6 (<0.1%) cases had missing and/or unknown site of disease.
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Table 39. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 1999 
Metropolitan Total Unknown or 
Statistical Area Cases Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+ Missing 
Akron, Ohio 14 0 0 0 4 5 5 0 
Albany-Schenectady, NY 19 0 1 1 6 5 6 0 
Albuquerque, NM 16 1 1 2 3 3 6 0 
Allentown, Pa 17 0 0 1 5 1 10 0 
Ann Arbor, Mich 15 1 0 1 9 3 1 0 
Atlanta, Ga 343 21 13 44 153 84 28 0 
Austin, Tex 90 9 1 15 33 26 6 0 
Bakersfield, Calif 62 3 2 8 20 19 10 0 
Baltimore, Md 134 4 1 13 41 39 36 0 
Baton Rouge, La 39 0 1 0 15 16 7 0 
Bergen-Passaic, NJ 104 3 1 6 48 21 25 0 
Birmingham, Ala 77 0 1 2 15 30 29 0 
Boston, Mass 267 5 4 36 114 59 49 0 
Buffalo, NY 25 0 0 2 7 9 7 0 
Charleston, SC 28 0 0 3 7 12 6 0 
Charlotte, NC 103 3 0 9 48 30 13 0 
Chicago, Ill 717 24 20 50 268 215 140 0 
Cincinnati, Ohio 42 1 1 1 7 19 13 0 
Cleveland, Ohio 109 2 0 7 27 29 44 0 
Columbia, SC 30 0 1 4 12 8 5 0 
Columbus, Ohio 62 0 1 11 23 17 10 0 
Dallas, Tex 255 10 2 25 107 79 32 0 
Dayton, Ohio 16 1 0 1 5 3 6 0 
Denver, Colo 65 7 4 5 22 15 12 0 
Detroit, Mich 231 5 8 11 74 71 62 0 
El Paso, Tex 61 3 3 2 14 13 26 0 
Fort Lauderdale, Fla 143 6 4 9 63 44 17 0 
Fort Worth, Tex 117 2 1 13 43 39 19 0 
Fresno, Calif 110 5 16 12 35 25 17 0 
Gary, Ind 22 0 1 0 4 7 10 0 
Grand Rapids, Mich 32 3 1 6 8 8 6 0 
Greensboro, NC 68 1 3 12 17 23 12 0 
Greenville, SC 34 0 0 2 13 15 4 0 
Harrisburg, Pa 11 1 0 0 2 4 4 0 
Hartford, Conn 48 3 2 9 19 11 4 0 
Honolulu, Hawaii 147 0 3 15 38 40 51 0 
Houston, Tex 482 23 13 35 202 149 60 0 
Indianapolis, Ind 50 6 1 5 16 8 14 0 
Jacksonville, Fla 105 2 0 3 47 30 23 0 
Jersey City, NJ 84 3 3 16 29 24 9 0 
Kansas City, Mo 63 1 2 4 22 23 11 0 
Knoxville, Tenn 42 2 0 1 11 16 12 0 
Las Vegas, Nev 68 2 2 6 18 28 12 0 
Little Rock, Ark 24 1 1 0 5 7 10 0 
Los Angeles, Calif 1,265 47 29 120 410 363 296 0 
Louisville, Ky 47 2 0 1 21 12 11 0 
McAllen, Tex 75 4 4 10 14 24 19 0 
Memphis, Tenn 97 10 3 10 45 19 10 0 
Miami, Fla 273 4 1 20 125 88 35 0 
Middlesex, NJ 82 0 0 12 30 19 21 0 
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Table 39. (Cont'd) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 1999 
Metropolitan Total Unknown or 
Statistical Area Cases Under 5 5 - 14 15 - 24 25 - 44 45 - 64 65+ Missing 
Milwaukee, Wis 59 2 2 6 22 11 16 0 
Minneapolis-St. Paul, Minn 161 4 12 51 52 28 14 0 
Mobile, Ala 34 0 0 0 10 14 10 0 
Monmouth-Ocean City, NJ 33 1 0 4 7 9 12 0 
Nashville, Tenn 85 1 1 6 33 26 18 0 
Nassau-Suffolk, NY 129 2 3 14 56 28 26 0 
New Haven, Conn 65 1 0 5 23 25 11 0 
New Orleans, La 122 5 3 7 44 43 20 0 
New York, NY 1,540 35 38 133 705 403 226 0 
Newark, NJ 181 5 6 15 81 51 23 0 
Norfolk, Va 62 2 0 8 17 18 17 0 
Oakland, Calif 338 17 11 40 94 91 85 0 
Oklahoma City, Okla 79 4 4 7 32 22 10 0 
Omaha, Neb 9 0 0 1 6 1 1 0 
Orange County, Calif 245 5 5 27 95 52 61 0 
Orlando, Fla 154 4 0 5 70 51 24 0 
Philadelphia, Pa 299 9 7 20 94 90 79 0 
Phoenix, Ariz 159 4 2 22 69 30 32 0 
Pittsburgh, Pa 62 1 2 3 14 11 31 0 
Portland, Ore 87 5 3 10 31 23 15 0 
Providence, RI 52 3 4 7 11 14 13 0 
Raleigh-Durham, NC 79 2 0 8 26 22 21 0 
Richmond, Va 28 0 1 2 4 8 13 0 
Riverside-San Bernardino, Calif 192 10 7 7 64 61 43 0 
Rochester, NY 30 1 0 2 14 6 7 0 
Sacramento, Calif 101 0 5 6 29 38 23 0 
St. Louis, Mo 98 7 3 4 41 21 22 0 
Salt Lake City, Utah 32 1 1 2 9 12 7 0 
San Antonio, Tex 100 1 0 10 33 32 24 0 
San Diego, Calif 297 18 23 24 99 65 68 0 
San Francisco, Calif 307 7 4 24 112 68 92 0 
San Jose, Calif 244 7 4 24 92 58 59 0 
Sarasota, Fla 19 1 0 0 10 6 2 0 
Scranton, Pa 23 1 0 2 1 6 13 0 
Seattle, Wash 127 1 1 22 50 26 27 0 
Springfield, Mass 12 0 0 0 4 4 4 0 
Stockton, Calif 74 3 2 7 17 30 15 0 
Syracuse, NY 37 3 5 5 8 8 8 0 
Tacoma, Wash 43 2 0 8 7 14 12 0 
Tampa-St. Petersburg, Fla 156 5 1 6 50 60 34 0 
Toledo, Ohio 10 1 0 1 3 4 1 0 
Tucson, Ariz 46 0 0 1 19 12 14 0 
Tulsa, Okla 46 4 1 4 17 11 9 0 
Vallejo, Calif 35 5 1 7 7 11 4 0 
Ventura, Calif 62 5 2 3 17 18 17 0 
Washington, DC 366 7 7 48 172 70 62 0 
West Palm Beach, Fla 108 2 2 9 48 31 16 0 
Wichita, Kan 29 3 2 3 11 6 4 0 
Wilmington, Del 15 0 1 0 8 2 4 0 
Youngstown, Ohio 10 0 0 0 1 1 8 0 
Total - 100 Areas 13,111 438 332 1,211 4,863 3,609 2,658 0 
San Juan, Puerto Rico 79 1 0 4 32 22 20 0 
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Table 40. Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with 
>500,000 Population, 1999 
American Indian Asian Unknown 
Metropolitan Total White, Black, or or or 
Statistical Area Cases non-Hispanic non-Hispanic Hispanic1 Alaskan Native Pacific Islander Missing 
Akron, Ohio

Albany-Schenectady, NY

Albuquerque, NM

Allentown, Pa

Ann Arbor, Mich

Atlanta, Ga

Austin, Tex

Bakersfield, Calif

Baltimore, Md

Baton Rouge, La

Bergen-Passaic, NJ

Birmingham, Ala

Boston, Mass

Buffalo, NY

Charleston, SC

Charlotte, NC

Chicago, Ill

Cincinnati, Ohio

Cleveland, Ohio

Columbia, SC

Columbus, Ohio

Dallas, Tex

Dayton, Ohio

Denver, Colo

Detroit, Mich

El Paso, Tex

Fort Lauderdale, Fla

Fort Worth, Tex

Fresno, Calif

Gary, Ind

Grand Rapids, Mich

Greensboro, NC

Greenville, SC

Harrisburg, Pa

Hartford, Conn

Honolulu, Hawaii

Houston, Tex

Indianapolis, Ind

Jacksonville, Fla

Jersey City, NJ

Kansas City, Mo

Knoxville, Tenn

Las Vegas, Nev

Little Rock, Ark

Los Angeles, Calif

Louisville, Ky

McAllen, Tex

Memphis, Tenn

Miami, Fla

Middlesex, NJ

14 6 8 0 0 0 0 
19 8 8 0 0 3 0 
16 1 0 9 6 0 0 
17 9 3 2 0 3 0 
15 5 5 1 0 4 0 
343 49 218 32 0 37 7 
90 18 25 34 0 13 0 
62 14 7 32 1 8 0 
134 27 76 7 0 24 0 
39 14 20 0 0 5 0 
104 20 18 27 0 39 0 
77 24 50 1 0 2 0 
267 74 72 34 0 86 1 
25 11 9 2 0 3 0 
28 6 18 1 0 3 0 
103 15 63 16 1 8 0 
717 128 323 132 0 130 4 
42 20 19 2 0 1 0 
109 31 64 4 0 10 0 
30 10 16 0 0 4 0 
62 16 27 2 1 15 1 
255 59 91 64 0 41 0 
16 8 5 1 0 2 0 
65 13 11 23 1 17 0 
231 57 125 10 2 35 2 
61 6 0 54 0 1 0 
143 28 84 20 0 11 0 
117 41 34 25 1 16 0 
110 14 13 56 1 26 0 
22 11 9 1 1 0 0 
32 6 3 9 0 14 0 
68 16 28 13 2 9 0 
34 8 20 1 0 5 0 
11 8 0 0 0 3 0 
48 8 16 12 0 12 0 
147 5 1 4 0 133 4 
482 81 170 169 0 62 0 
50 19 20 5 0 6 0 
105 37 54 0 1 13 0 
84 7 25 30 0 22 0 
63 9 32 8 0 14 0 
42 31 7 1 0 3 0 
68 15 9 15 0 28 1 
24 16 7 0 0 1 0 
1,265 127 152 591 3 389 3 
47 24 17 3 0 3 0 
75 1 0 70 0 4 0 
97 11 81 1 0 4 0 
273 31 133 98 0 11 0 
82 21 9 17 0 35 0 
1. Persons of Hispanic origin may be of any race. 
54 
Table 40. (Cont'd) Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with 
>500,000 Population, 1999 
American Indian Asian Unknown 
Metropolitan Total White, Black, or or or 
Statistical Area Cases non-Hispanic non-Hispanic Hispanic1 Alaskan Native Pacific Islander Missing 
Milwaukee, Wis 
Minneapolis-St. Paul, Minn 
Mobile, Ala 
Monmouth-Ocean City, NJ 
Nashville, Tenn 
Nassau-Suffolk, NY 
New Haven, Conn 
New Orleans, La 
New York, NY 
Newark, NJ 
Norfolk, Va 
Oakland, Calif 
Oklahoma City, Okla 
Omaha, Neb 
Orange County, Calif 
Orlando, Fla 
Philadelphia, Pa 
Phoenix, Ariz 
Pittsburgh, Pa 
Portland, Ore 
Providence, RI 
Raleigh-Durham, NC 
Richmond, Va 
59 17 19 6 0 17 0 
161 17 79 12 5 48 0 
34 13 16 0 1 4 0 
33 13 4 6 0 10 0 
85 33 43 5 0 4 0 
129 31 32 44 0 22 0 
65 15 18 16 0 16 0 
122 43 66 6 1 5 1 
1,540 188 579 412 0 360 1 
181 18 110 33 0 20 0 
62 18 29 4 0 11 0 
338 40 83 65 1 149 0 
79 43 11 2 12 11 0 
9 6 1 1 0 1 0 
245 23 5 84 0 133 0 
154 43 89 17 0 5 0 
299 54 129 21 0 90 5 
159 53 11 70 12 13 0 
62 37 11 0 0 14 0 
87 24 8 18 0 37 0 
52 16 11 12 0 13 0 
79 21 41 7 0 9 1 
28 8 11 0 0 9 0 
Riverside-San Bernardino, Calif 192 35 19 86 1 51 
Rochester, NY

Sacramento, Calif

St. Louis, Mo

Salt Lake City, Utah

San Antonio, Tex

San Diego, Calif

San Francisco, Calif

San Jose, Calif

Sarasota, Fla

Scranton, Pa

Seattle, Wash

Springfield, Mass

Stockton, Calif

Syracuse, NY

Tacoma, Wash

Tampa-St. Petersburg, Fla

Toledo, Ohio

Tucson, Ariz

Tulsa, Okla

Vallejo, Calif

Ventura, Calif

Washington, DC

West Palm Beach, Fla

Wichita, Kan

Wilmington, Del

Youngstown, Ohio

30 9 11 4 0 6 0 
101 22 10 8 2 50 9 
98 24 56 3 1 13 1 
32 8 3 6 6 9 0 
100 20 7 70 0 3 0 
297 34 22 137 3 101 0 
307 34 37 45 0 191 0 
244 12 6 40 0 186 0 
19 5 6 7 0 1 0 
23 17 0 3 0 3 0 
127 31 26 14 3 53 0 
12 6 3 2 0 1 0 
74 13 3 20 0 38 0 
37 10 21 1 0 5 0 
43 15 5 4 2 16 1 
156 70 53 14 0 19 0 
10 3 5 2 0 0 0 
46 19 3 18 3 3 0 
46 23 9 6 6 2 0 
35 3 10 5 0 17 0 
62 10 1 37 0 14 0 
366 61 147 71 0 86 1 
108 26 66 14 0 2 0 
29 10 7 6 0 6 0 
15 5 2 2 0 6 0 
10 7 3 0 0 0 0 
Total - 100 Areas 13,111 2,530 4,152 3,105 80 3,201 43 
San Juan, Puerto Rico 79 0 0 78 0 0 1 
1. Persons of Hispanic origin may be of any race. 
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Table 41. Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons:
Metropolitan Statistical Areas with >500,000 Population, 1999 
Metropolitan Total U.S.-born Persons Foreign-born Persons1 Unknown 
Statistical Area Cases No. % No. % No. % 
Akron, Ohio 14 13 92.9 1 7.1 0 0.0 
Albany-Schenectady, NY 19 12 63.2 7 36.8 0 0.0 
Albuquerque, NM 16 11 68.8 5 31.3 0 0.0 
Allentown, Pa 17 11 64.7 6 35.3 0 0.0 
Ann Arbor, Mich 15 5 33.3 10 66.7 0 0.0 
Atlanta, Ga 343 239 69.7 96 28.0 8 2.3 
Austin, Tex 90 47 52.2 43 47.8 0 0.0 
Bakersfield, Calif 62 36 58.1 26 41.9 0 0.0 
Baltimore, Md 134 96 71.6 38 28.4 0 0.0 
Baton Rouge, La 39 32 82.1 7 17.9 0 0.0 
Bergen-Passaic, NJ 104 35 33.7 69 66.3 0 0.0 
Birmingham, Ala 77 74 96.1 3 3.9 0 0.0 
Boston, Mass 267 86 32.2 181 67.8 0 0.0 
Buffalo, NY 25 20 80.0 5 20.0 0 0.0 
Charleston, SC 28 24 85.7 4 14.3 0 0.0 
Charlotte, NC 103 79 76.7 24 23.3 0 0.0 
Chicago, Ill 717 461 64.3 243 33.9 13 1.8 
Cincinnati, Ohio 42 36 85.7 6 14.3 0 0.0 
Cleveland, Ohio 109 86 78.9 23 21.1 0 0.0 
Columbia, SC 30 26 86.7 4 13.3 0 0.0 
Columbus, Ohio 62 33 53.2 29 46.8 0 0.0 
Dallas, Tex 255 147 57.6 108 42.4 0 0.0 
Dayton, Ohio 16 11 68.8 4 25.0 1 6.3 
Denver, Colo 65 24 36.9 41 63.1 0 0.0 
Detroit, Mich 231 182 78.8 48 20.8 1 0.4 
El Paso, Tex 61 23 37.7 38 62.3 0 0.0 
Fort Lauderdale, Fla 143 64 44.8 79 55.2 0 0.0 
Fort Worth, Tex 117 74 63.2 43 36.8 0 0.0 
Fresno, Calif 110 51 46.4 59 53.6 0 0.0 
Gary, Ind 22 19 86.4 3 13.6 0 0.0 
Grand Rapids, Mich 32 10 31.3 22 68.8 0 0.0 
Greensboro, NC 68 46 67.6 22 32.4 0 0.0 
Greenville, SC 34 28 82.4 6 17.6 0 0.0 
Harrisburg, Pa 11 6 54.5 5 45.5 0 0.0 
Hartford, Conn 48 21 43.8 27 56.3 0 0.0 
Honolulu, Hawaii 147 38 25.9 108 73.5 1 0.7 
Houston, Tex 482 299 62.0 182 37.8 1 0.2 
Indianapolis, Ind 50 36 72.0 13 26.0 1 2.0 
Jacksonville, Fla 105 86 81.9 19 18.1 0 0.0 
Jersey City, NJ 84 32 38.1 52 61.9 0 0.0 
Kansas City, Mo 63 42 66.7 21 33.3 0 0.0 
Knoxville, Tenn 42 37 88.1 5 11.9 0 0.0 
Las Vegas, Nev 68 23 33.8 45 66.2 0 0.0 
Little Rock, Ark 24 23 95.8 1 4.2 0 0.0 
Los Angeles, Calif 1,265 349 27.6 902 71.3 14 1.1 
Louisville, Ky 47 42 89.4 5 10.6 0 0.0 
McAllen, Tex 75 28 37.3 47 62.7 0 0.0 
Memphis, Tenn 97 91 93.8 6 6.2 0 0.0 
Miami, Fla 273 110 40.3 163 59.7 0 0.0 
Middlesex, NJ 82 19 23.2 63 76.8 0 0.0 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 
Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands. 
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Table 41. (Cont'd) Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons:
Metropolitan Statistical Areas with >500,000 Population, 1999 
Metropolitan Total U.S.-born Persons Foreign-born Persons1 Unknown 
Statistical Area Cases No. % No. % No. % 
Milwaukee, Wis 59 38 64.4 21 35.6 0 0.0 
Minneapolis-St. Paul, Minn 161 34 21.1 127 78.9 0 0.0 
Mobile, Ala 34 29 85.3 5 14.7 0 0.0 
Monmouth-Ocean City, NJ 33 17 51.5 16 48.5 0 0.0 
Nashville, Tenn 85 64 75.3 21 24.7 0 0.0 
Nassau-Suffolk, NY 129 47 36.4 82 63.6 0 0.0 
New Haven, Conn 65 22 33.8 42 64.6 1 1.5 
New Orleans, La 122 106 86.9 14 11.5 2 1.6 
New York, NY 1,540 610 39.6 856 55.6 74 4.8 
Newark, NJ 181 96 53.0 83 45.9 2 1.1 
Norfolk, Va 62 44 71.0 18 29.0 0 0.0 
Oakland, Calif 338 131 38.8 207 61.2 0 0.0 
Oklahoma City, Okla 79 63 79.7 16 20.3 0 0.0 
Omaha, Neb 9 4 44.4 5 55.6 0 0.0 
Orange County, Calif 245 32 13.1 212 86.5 1 0.4 
Orlando, Fla 154 119 77.3 34 22.1 1 0.6 
Philadelphia, Pa 299 179 59.9 113 37.8 7 2.3 
Phoenix, Ariz 159 82 51.6 76 47.8 1 0.6 
Pittsburgh, Pa 62 47 75.8 15 24.2 0 0.0 
Portland, Ore 87 29 33.3 58 66.7 0 0.0 
Providence, RI 52 26 50.0 26 50.0 0 0.0 
Raleigh-Durham, NC 79 55 69.6 23 29.1 1 1.3 
Richmond, Va 28 17 60.7 11 39.3 0 0.0 
Riverside-San Bernardino, Calif 192 82 42.7 109 56.8 1 0.5 
Rochester, NY 30 19 63.3 11 36.7 0 0.0 
Sacramento, Calif 101 39 38.6 52 51.5 10 9.9 
St. Louis, Mo 98 77 78.6 20 20.4 1 1.0 
Salt Lake City, Utah 32 16 50.0 16 50.0 0 0.0 
San Antonio, Tex 100 70 70.0 26 26.0 4 4.0 
San Diego, Calif 297 98 33.0 199 67.0 0 0.0 
San Francisco, Calif 307 77 25.1 230 74.9 0 0.0 
San Jose, Calif 244 20 8.2 224 91.8 0 0.0 
Sarasota, Fla 19 15 78.9 4 21.1 0 0.0 
Scranton, Pa 23 16 69.6 7 30.4 0 0.0 
Seattle, Wash 127 44 34.6 83 65.4 0 0.0 
Springfield, Mass 12 4 33.3 8 66.7 0 0.0 
Stockton, Calif 74 18 24.3 56 75.7 0 0.0 
Syracuse, NY 37 31 83.8 6 16.2 0 0.0 
Tacoma, Wash 43 22 51.2 21 48.8 0 0.0 
Tampa-St. Petersburg, Fla 156 120 76.9 36 23.1 0 0.0 
Toledo, Ohio 10 8 80.0 2 20.0 0 0.0 
Tucson, Ariz 46 30 65.2 16 34.8 0 0.0 
Tulsa, Okla 46 37 80.4 9 19.6 0 0.0 
Vallejo, Calif 35 16 45.7 19 54.3 0 0.0 
Ventura, Calif 62 26 41.9 36 58.1 0 0.0 
Washington, DC 366 118 32.2 248 67.8 0 0.0 
West Palm Beach, Fla 108 59 54.6 49 45.4 0 0.0 
Wichita, Kan 29 19 65.5 9 31.0 1 3.4 
Wilmington, Del 15 8 53.3 7 46.7 0 0.0 
Youngstown, Ohio 10 8 80.0 2 20.0 0 0.0 
Total - 100 Areas ##### 6,411 48.9 6,553 50.0 147 1.1 
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 
Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands. 
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 Appendix A 
 
 
Technical Notes 
        
National Surveillance for Tuberculosis 
      All reporting areas (i.e., the 50 states, the District of Columbia, New York City, Puerto Rico, 
and other U.S. jurisdictions in the Pacific and Caribbean) report tuberculosis (TB) cases to CDC 
using a standard case report form, Report of a Verified Case of Tuberculosis (RVCT).1   Reported 
TB cases are verified according to the TB case definition for public health surveillance (MMWR 
1997;46[No. RR-10]:40-1).  Cases may be verified using the laboratory or clinical case 
definition.  A case may be verified by the laboratory case definition either by (1) isolation of M. 
tuberculosis from a clinical specimen, OR (2) demonstration of acid-fast bacilli (AFB) in a 
clinical specimen when a culture has not been or cannot be obtained.  A case may be verified by 
the clinical case definition in the presence of ALL of the following clinical criteria: (a) a positive 
tuberculin skin test result, (b) other signs and symptoms compatible with TB, such as an 
abnormal, unstable (worsening or improving) chest radiograph, or clinical evidence of current 
disease, (c) treatment with two or more antituberculosis medications, and (d) a completed 
diagnostic evaluation.  When patients are diagnosed with TB but do not meet the case definition 
(e.g., anergic patients with a clinical picture consistent with TB but without laboratory evidence 
of M. tuberculosis), reporting areas also have the option of verifying TB cases based on provider 
diagnosis.  
      In January 1993, in conjunction with state and local health departments, CDC implemented 
an expanded surveillance system for TB to collect additional data to better monitor and target 
groups at risk for TB disease, to estimate and follow the extent of drug-resistant TB, and to 
evaluate outcomes of TB cases.  The RVCT form for reporting TB cases was revised to collect 
information on occupation, the initial drug regimen, human immunodeficiency virus (HIV) test 
results, history of substance abuse and homelessness, and residence in correctional or long-term 
care facilities at the time of diagnosis.  RVCT Follow Up Report-1 was added to collect drug 
susceptibility results for the initial M. tuberculosis isolate from patients with culture-positive 
disease.  To evaluate the outcomes of TB therapy, RVCT Follow Up Report-2 was added to 
collect information on the reason and date therapy was stopped, the type of health care provider, 
sputum culture conversion, the use of directly observed therapy, and the results of drug 
susceptibility testing for the final M. tuberculosis isolate from patients with culture-positive 
disease.  Since 1993, RVCT data have been reported to CDC using software specifically 
developed for expanded TB surveillance (i.e., SURVS-TB, 1993-1997; TIMS, 1998-1999).  The 
instructions for completing the RVCT forms and the definitions for all data items were included 
in the software user’s guide.  The summary data presented in this publication for 1999 (and for  
1997, Tables 33-35) and the trend data for 1993-1999 (Tables 7-10) were received at CDC via 
TIMS by May 3, 2000. 
 
__________________________________________________ 
 
 
1Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Micronesia, 
Guam, the Republic of the Marshall Islands, the Republic of Palau, and the U.S. Virgin Islands.  RVCT data for 1999 were available from 
American Samoa, the Commonweatlth of the Northern Mariana Islands, Guam, and the Republic of Palau. 
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Completion of Tuberculosis Therapy       
      Tables 9 and 35 are recent additions to this publication and present rates of completion of TB 
therapy (COT).  Data collected by RVCT Follow Up Report-2 on date and reason therapy stopped 
(e.g., patient completed therapy, moved, was lost) were used to calculate rates of COT.  Cases were 
stratified by the indicated length of therapy, based on current American Thoracic Society/CDC 
treatment guidelines2 and the patient’s initial drug susceptibility test results, age, and site of disease. 
 The adequacy of the treatment regimen (e.g., the sufficiency of the duration of therapy, the 
appropriateness of the prescribed TB drugs) was not evaluated in this analysis.  Acquired drug 
resistance during therapy with the need for a longer duration of therapy was also not considered in 
this analysis. 
      In Table 35, the first column shows the total number of cases reported during 1997.  The 
remaining columns are grouped under three headings: therapy of 1 year or less indicated, therapy 
greater than 1 year indicated, and overall.  For patients with an initial isolate resistant to rifampin 
and for pediatric patients (age under 15 years old) with meningeal, bone or joint, or miliary disease, 
data were included under the category of greater than 1 year of therapy indicated.  For all other 
patients, including those with culture-negative disease, those with an unknown culture status, and 
those with culture-positive disease but unknown initial drug susceptibility test results, data were 
included under the category of 1 year or less of therapy indicated.  Table 9 presents data only for 
the category of therapy of 1 year or less indicated.     
      In Table 35, each group under an indicated length of therapy has an initial column showing the 
number of cases in persons who were alive at diagnosis and prescribed an initial regimen of one or 
more drugs, and who did not die during therapy.  This number was used as the denominator in COT 
rate calculations.  COT rates, shown as percentages, were only calculated for areas reporting reason 
therapy stopped for at least 90% of cases shown in the overall column.  For the group with an 
indicated length of therapy of 1 year or less, rates are shown for both completion of therapy in 1 
year or less (COT <1 year) and for COT, regardless of duration of therapy (i.e., duration of therapy 
<1 year, >1 year, or unknown).  For COT <1 year, the numerator included only those patients 
completing therapy in <365 days (based on the dates therapy started and stopped).  Patients with 
missing dates were classified as “treatment not completed” for this calculation.  Rates of COT, 
regardless of duration of therapy, were calculated by dividing the number of patients reported as 
having completed therapy by the number of patients listed in the first column of each group.  
Patients with an outcome other than completed therapy (i.e., moved, lost, refused treatment, and 
other) were classified as “treatment not completed.”  Patients with an unknown outcome were also 
classified as “treatment not completed.”  For the remaining two groups of indicated therapy length 
(greater than 1 year and overall), only rates of COT, regardless of duration of therapy, are 
presented.  Table 9 provides rates for COT <1 year and for COT, regardless of duration of therapy, 
only for the group with an indicated therapy of 1 year or less. 
 
Acknowledgment: Tables 9 and 35 were developed in collaboration with the Field Services Branch, 
Division of Tuberculosis Elimination, CDC.  
  
 
                                                                                                              
                                                                       
2ATS/CDC. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74. 
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Site of TB Disease   
      Tables 5, 6, 21, 22, and 38 reflect a recent change in the definition of miliary disease that is used in 
this publication.  Miliary disease is now classified as both an extrapulmonary and a pulmonary form of 
TB.  In publications prior to 1997, miliary disease was classified as extrapulmonary TB unless 
pulmonary disease was reported as the major site of TB disease.    
  
Reporting of HIV Infection  
      Table 31 shows information on HIV status for TB cases among persons aged 25-44 years, the age 
group in which 75% of AIDS cases occur (CDC. HIV/AIDS Surveillance Report 1999;11[No. 2]:16).  
The information on HIV status for TB cases reported in 1999 is incomplete.  Reasons for incomplete 
reporting of HIV test results to the national surveillance system include concerns about confidentiality, 
which may limit the exchange of data between TB and HIV/AIDS programs; laws and regulations in 
certain states and local jurisdictions that have been interpreted as prohibiting the HIV/AIDS program 
from sharing the HIV status of TB patients with the TB program, or from reporting patients with TB 
and AIDS to the TB program; and reluctance by health care providers to report HIV test results to the 
TB surveillance program staff.  In addition, health care providers may not offer counseling and HIV 
testing to some TB patients because of a lack of resources or of appropriately trained staff, or due to 
the perception that selected patients (e.g., foreign-born persons) are not at risk for HIV infection. 
      Data on the HIV infection status of reported TB cases in 1999 should be interpreted with caution.  
These data are not representative of all TB patients with HIV infection.  HIV testing is performed after 
a patient receives counseling and gives informed consent.  Since testing is voluntary, some TB patients 
may decline HIV testing.  TB patients who are tested anonymously may choose not to share the results 
of HIV testing with their health care provider.  TB patients managed in the private sector may receive 
confidential HIV testing, but results may not be reported to the TB program in the health department.  
In addition, many factors may influence HIV testing of TB patients, including the extent to which 
testing is targeted or routinely offered to specific groups (e.g., 25- to 44- year-old males, injecting 
drug users, homeless persons), and the availability of and access to HIV testing services.  These data 
do not provide a minimum estimate of the proportion of TB patients known to be HIV infected in a 
reporting area. 
  
Tabulation and Presentation of TB Data   
      This report primarily presents summary data for TB cases reported to CDC in 1999.  Data from the 
RVCT Follow Up Report-2 (i.e., completion of therapy, use of directly observed therapy, and  type of 
health care provider) are presented for cases reported in 1997.  In addition, trend data are presented in 
Tables 1 through 10.  TB cases are tabulated by the year in which the reporting area verified that the 
patient had TB and included the patient in its official annual TB case count.  Totals for the U.S. only 
include data from the 50 states, the District of Columbia, and New York City.  Age group tabulations 
are based on the patient’s age in the month and year the patient was reported to the health department 
as a suspected TB case.  State or metropolitan area data tabulations are based on the patient’s 
residence at diagnosis of TB (see Appendix C: “Recommendations for Counting Reported 
Tuberculosis Cases”). 
      Tables 37 through 41 present data by metropolitan statistical areas (MSAs) with an estimated 1999 
population of 500,000 or more.  Metropolitan areas are defined by the federal Office of Management 
and Budget, and the definitions effective as of June 30, 1998, were used for this publication 
(www.census.gov/population/www/estimates/pastmetro.html).  The metropolitan area definitions 
apply to all areas except the six New England states; for these states, the New England County 
Metropolitan Areas (NECMAs) are used.  Metropolitan areas are named for a central city in the MSA 
or NECMA, may include several cities and counties, and may cross state boundaries.  For example, 
the TB cases and case rates presented for the District of Columbia in Table 15 include only persons 
residing within the geographic boundaries of the District.  However, the TB cases and case rates for 
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Washington, D.C. (Table 37), include persons residing within the several counties in the metropolitan 
area, including counties in Maryland, Virginia, and West Virginia.  A list of the cities and counties 
that comprised each metropolitan area in 1998 is available from the National Technical Information 
Service (1-800-553-NTIS, accession no. PB98-502198, Metropolitan Areas for 1998).  
  
Rates 
      Rates are expressed as the number of cases reported each calendar year per 100,000 population. 
 Population denominators used in calculating TB rates are based on official midyear (July 1) post-
census estimates from the U.S. Census Bureau.  In Tables 1 and 15, the U.S. total and state 
populations for 1999 were obtained from State Population Estimates: Annual Time Series, July 1, 
1990, to July 1, 1999, ST-99-3 (www.census.gov/population/estimates/state/st-99-3.txt).  In Tables 
2, 3, and 12, populations by age, sex, race, and Hispanic origin were obtained from National 
Population Estimates for the 1990's: Monthly Postcensal Resident Population, by Single Year of 
Age, Sex, Race, and Hispanic Origin (www.census.gov/population/estimates/nation/e90s/ 
e9999rmp.txt).  The populations for U.S.-born and foreign-born populations (Table 4) were 
obtained from Quarterly Estimates of the United States Foreign-born and Native Resident 
Populations: April 1, 1990, to July 1, 1999 (www.census.gov/population/estimates/nation/nativity/ 
fbtab001.txt). 
 
Mortality Data 
      Official TB mortality statistics for the United States are compiled by the National Center for 
Health Statistics (NCHS), CDC.  The annual mortality rate is calculated as the number of deaths 
due to TB in that year, divided by the estimated population for the year, multiplied by 100,000 
(Table 1).  The number of deaths for 1998 was obtained from the NCHS National Vital Statistics 
Reports (Vol. 47, No. 25), October 5, 1999.  The number of deaths for 1999 was not available at the 
time of this publication. 
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 Appendix B 
 
 
Tuberculosis Case Definition for Public Health Surveillance1 
  
Tuberculosis (Revised 9/96) 
  
Clinical description 
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized pathologically 
by the formation of granulomas. The most common site of infection is the lung, but other organs 
may be involved.  
  
Clinical case definition 
A case that meets the following criteria: 
 A positive tuberculin skin test 
 Other signs and symptoms compatible with tuberculosis (e.g. an abnormal, unstable              
[i.e., worsening or improving] chest radiographs, or clinical evidence of current disease) 
 Treatment with two or more antituberculosis medications 
 Completed diagnostic evaluation 
   
Laboratory criteria for diagnosis 
 Isolation of M. tuberculosis from a clinical specimen* or 
 Demonstration of M. tuberculosis from a clinical specimen by nucleic acid                            
amplification test†, or   
 Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or 
cannot be obtained.  
   
Case classification 
Confirmed: a case that meets the clinical case definition or is laboratory confirmed 
  
Comment 
A case should not be counted twice within any consecutive 12-month period. However, cases in 
which the patients had previously had verified disease should be reported again if the patients 
were discharged from treatment. Cases also should be reported again if patients were lost to 
supervision  for >12 months and disease can be verified again. Mycobacterial diseases other 
than those caused by M. tuberculosis complex should not be counted in tuberculosis morbidity 
statistics unless there is concurrent tuberculosis. 
------------------------------------------------------------------------------------------------------------------ 
1CDC. Case definitions for infectious conditions under public health surveillance.  MMWR   
1997;46(No. RR-10):40-41.) 
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic 
  acids high-pressure liquid chromatography performed on a culture from a clinical specimen) 
  are acceptable under this criterion. 
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria 
  species. However, for surveillance purposes, CDC will accept results obtained from NAA 
  tests approved by the Food and Drug Administration (FDA) and used according to the 
  approved product labeling on the package insert. Current FDA-approved NAA tests are only 
  approved for smear-positive respiratory specimens. 
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 Appendix C 
 
 
  Recommendations for Counting Reported Tuberculosis Cases  
 (Revised July 1997)  
 
  
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in 
January 1977, numerous changes have occurred and many issues have been raised within the 
field of tuberculosis (TB) surveillance. This current version updates and supersedes the previous 
version; it clarifies the parameters for counting TB cases among (a) immigrants, resident aliens, 
and border crossers, (b) military personnel stationed in the United States and abroad, and (c) 
persons diagnosed within the Indian Health Service and correctional facilities. 
  
A distinction should be made between reporting TB cases to a health department and counting 
TB cases for determining incidence of disease. Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers. From these reports, the state or local TB control officer must 
determine which cases meet the current surveillance definition for TB disease. These verified TB 
cases are then counted and reported to the Centers for Disease Control and Prevention (CDC). 
  
I.    Reporting TB Cases.—CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments based on 
the current “Case Definition for Public Health Surveillance.”2 This notification is essential in 
order for TB programs to 
 Ensure case supervision 
 Ensure completion of appropriate therapy 
 Ensure completion of timely contact investigations 
 Evaluate program effectiveness  
 Assess trends and characteristics of TB morbidity 
   
II. TB Surveillance.—For purposes of surveillance, a case of TB is defined on the basis of 
laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.* 
  
________________________________ 
*Mycobacterium tuberculosis complex (M. tuberculosis complex) consists of three mycobacterial species: M. 
tuberculosis, M. bovis, and M. africanum. These species are identical in DNA homology studies. In terms of their ability 
to cause clinical disease and be transmissible from person to person, M. bovis and M. africanum behave like M. 
tuberculosis; therefore, disease caused by any of the three organisms should be reported as TB, using the Report of 
Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of M. bovis, which may be isolated from 
persons who have received the vaccine for protection against TB or as cancer immunotherapy; disease caused by this M. 
bovis strain should not be reported as TB because the transmission is iatrogenic (treatment-induced), rather than person-
to-person or communicable. 
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a.  Laboratory Case Definition. 
  
 Isolation of M. tuberculosis complex from a clinical specimen. The use of rapid- 
identification techniques for M. tuberculosis performed on a culture from a clinical 
specimen, such as DNA probes and high-pressure liquid chromatography (HPLC), is  
acceptable under this criterion. 
  
OR 
 
 Demonstration of M. tuberculosis from a clinical specimen by nucleic acid   
amplification (NAA) test. NAA tests must be accompanied by cultures of   
mycobacterial species. However, for surveillance purposes, CDC will accept results 
obtained from NAA tests that are approved by the Food and Drug Administration 
(FDA) and used according to the approved product labeling on the package insert. 
Current FDA-approved NAA tests are only approved for use on smear-positive 
respiratory specimens. 
 
                                                         OR    
 
 Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture 
has not been or cannot be obtained; historically this criterion has been most 
commonly used to diagnose TB in the postmortem setting.   
 
b. Clinical Case Definition.—In the absence of laboratory confirmation of M. tuberculosis 
complex after a diagnostic process has been completed, persons must have all of the 
following criteria for clinical TB: 
  
 Evidence of TB infection based on a positive tuberculin skin test 
  
AND  
   
 One of the following: 
(1) Signs and symptoms compatible with current TB disease, such as an           
abnormal, unstable (worsening or improving) chest radiograph, or 
         (2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight 
             loss, hemoptysis) 
  
AND 
  
 Current treatment with two or more anti-TB medications  
  
NOTE: The case definition described herein was developed for use in this document and is not 
intended to replace the case definition for TB as stated in the current “Case Definitions for 
Infectious Conditions Under Public Health Surveillance.” 
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In addition, the software for TB surveillance developed by CDC includes a calculated variable 
called “Vercrit,” for which one of the values is “Provider Diagnosis.” “Provider Diagnosis” 
is selected when the user chooses to override a “Suspect” default value in the case verification 
screen as “Verified by Provider Diagnosis.” Thus, “Provider Diagnosis” is not a component 
of the case definition for TB in the current “Case Definitions for Infectious Conditions Under 
Public Health Surveillance” publication. CDC’s national morbidity reports have traditionally 
included all cases that are considered verified by the reporting areas, without a requirement 
that cases meet the published case definition. 
 
III. Counting TB Cases.—Cases that meet the current CDC surveillance case definition 
for verified TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States. The 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands) report 
cases to the CDC but are not included in the annual incidence for the United States. Laboratory 
and clinical case definitions are the two primary diagnostic categories used by the CDC “Case 
Definitions for Infectious Conditions Under Public Health Surveillance.”  
  
Most verified TB cases are accepted for counting based on laboratory confirmation of M. 
tuberculosis complex from a clinical specimen. 
  
A person may have more than one discrete (separate and distinct) episode of TB. If disease 
recurs in a person within any 12-consecutive-month period, count only one episode as a case 
for that year. However, if TB disease recurs in a person, and if more than 12 months have 
elapsed since the person was discharged from or lost to supervision, the TB is considered a 
separate episode and should be counted as a new case. 
  
Mycobacterial diseases other than those caused by M. tuberculosis complex should not be 
counted in TB morbidity statistics unless there is concurrent TB.  
 
a. Verified TB Cases. 
  
COUNT 
Count only verified TB cases that meet the laboratory or clinical case definitions (see 
Section II). The diagnosis of TB must be verified by the TB control officer or designee. 
The current CDC surveillance case definition for TB describes and defines the criteria 
to be used in the case definition for TB disease.  
  
DO NOT COUNT 
If diagnostic procedures have not been completed, do not count; wait for confirmation 
of disease. Do not count a case for which two or more anti-TB medications have been 
prescribed for preventive therapy for exposure to multidrug-resistant (MDR) TB, or 
while the diagnosis is still pending. 
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b. Nontuberculous Mycobacterial Diseases (NTM). 
  
COUNT 
An episode of TB disease diagnosed concurrently with another nontuberculous 
mycobacterial disease should be counted as a TB case. 
  
DO NOT COUNT 
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.  
 
c. TB Cases Reported at Death. 
  
COUNT 
TB cases first reported to the health department at the time of a person’s death are 
counted as incident cases provided that the person had current disease at the time of 
death. The TB control officer should verify the diagnosis of TB. 
  
DO NOT COUNT 
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy. 
  
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign 
Visitors.4 
  
COUNT 
Immigrants and refugees who have been screened overseas for TB and 
 have been classified as Class B (B1, B2, or B3)3 or resident aliens 
 are not already on anti-TB medications for treatment of tuberculous disease, and 
 are examined after arriving in the United States and diagnosed with clinically 
active TB requiring anti-TB medications should be counted by the locality of 
their current residence at the time of diagnosis regardless of citizenship status. 
  
Border crossers* and permanent resident aliens who are diagnosed with TB and plan to 
receive anti-TB therapy from a locality in the United States for 90 days or more should 
be counted by the locality where they receive anti-TB therapy. 
  
Foreign visitors (e.g., students, commercial representatives, and diplomatic personnel) 
who are diagnosed with TB, are receiving anti-TB therapy, and plan to remain in the 
United States for 90 days or more should be counted by the locality of current 
residence. 
  
*Border crosser - defined, in part, by the Immigration and Naturalization Service 
(INS)4 as “a nonresident alien entering the United States across the Mexican border for 
stays of no more than 72 hours.” Border crossers may go back and forth across the 
border many times in a short period. 
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DO NOT COUNT 
TB cases in immigrants or refugees who have been classified as Class A with a waiver 
(TB, infectious, “Noncommunicable for travel purposes”)3 should not be counted as 
new cases even if the persons receive routine initial work-ups in the United States.  
  
TB in persons who are temporarily (<90 days) in the United States, for whom therapy 
may have been started but who plan to return to their native country to continue 
therapy, should not be counted in the United States. 
 
 e. Out-of-State or Out-of-Area Residents.  
  
COUNT 
A person’s TB case should be counted by the locality in which he or she resides at the 
time of diagnosis. TB in a person who has no address should be counted by the locality 
that diagnosed and is treating the TB. The TB control officer should notify the 
appropriate out-of-state or out-of-area TB control officer of the person’s home locality 
to (1) determine whether the case has already been counted to avoid “double counting,” 
and (2) agree on which TB control office should count the case if it has not yet been    
counted.  
   
DO NOT COUNT  
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident and 
whose TB has already been counted by the out-of-area TB control office. 
 
f. Migrants and Other Transients.  
  
COUNT 
Persons without any fixed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and counted 
where diagnosed. 
  
DO NOT COUNT 
Cases in transient TB patients should not be counted when there is evidence that they 
have already been counted by another locality. 
  
g. Federal Facilities (e.g., Military and Veterans Administration Facilities).    
 
COUNT 
Cases in military personnel, dependents, or veterans should be reported and counted by 
the locality where the persons are residing in the United States at the time of diagnosis 
and initiation of treatment. 
  
However, if military personnel or dependents are discovered to have TB at a military 
base outside the United States but are referred elsewhere for treatment (e.g., a military 
base located within the United States), the TB case should be reported and counted 
where treated and not where the diagnosis was made. 
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DO NOT COUNT 
Do not count if the case was already counted by another locality in the United States. 
 
h. Indian Health Service. 
  
COUNT 
TB should be reported to the local health authority (e.g., state or county) and counted 
where diagnosed and treatment initiated. However, for a specific group such as the 
Navajo Nation, which is geographically located in multiple states, health departments 
should discuss each case and determine which locality should count the case. 
  
DO NOT COUNT 
Do not count if the case was already counted by another locality. 
  
i. Correctional Facilities (e.g., Local, State, Federal, and Military). 
  
COUNT 
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities. TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated. 
 
DO NOT COUNT 
Do not count correctional facility residents’ TB cases that were counted elsewhere by 
another locality or correctional facility, even if treatment continues at another locale or 
correctional facility. 
  
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States. 
  
DO NOT COUNT 
TB in persons diagnosed outside the United States should not be counted. TB in these 
persons should be counted by the country in which they are residing regardless of their 
plans to return to the United States for further work-up or treatment. 
  
IV. Suggested Administrative Practices.—To promote uniformity in TB case counting, 
the following administrative procedures are recommended: 
  
(a) All TB cases verified during the calendar year by the 52 reporting areas with count 
authority (50 states, District of Columbia, and New York City) by December 31 will be 
included in the annual U.S. incidence count for that year. All tuberculosis cases verified 
during the calendar year by a reporting area with count authority from one of the 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands) 
are also counted but are not included in the annual incidence for the United States. 
Cases for which bacteriologic results are pending or for which confirmation of 
disease is questionable for any other reason should not be counted until their status is  
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clearly determined; they should be counted at the time they meet the criteria for 
counting. This means that a case reported in one calendar year could be included 
in the morbidity count for the following year. The reporting area with count 
authority should ensure that there is agreement between final local and state TB 
figures reported to CDC. Currently, some reporting areas may not use this 
suggested protocol. Some of these areas may wait until the beginning of the 
following year when they have received and processed all of the TB cases for 
inclusion in the annual case count for the previous year. If reporting areas decide 
to revise their protocols, they should be aware that TB trends may change.  
 
(b) TB is occasionally reported to health departments over the telephone, by letter 
or fax, or on forms other than the Report of Verified Case of Tuberculosis 
(RVCT). Such information should be accepted as an official morbidity report if 
sufficient details are provided; otherwise, the notification should be used as an 
indicator of a possible TB case (suspect) which should be investigated promptly 
for confirmation. 
  
V. TB Surveillance Definitions. 
  
Case - an episode of TB disease in a person meeting the laboratory or clinical 
criteria for TB as defined in the document “Case Definitions for Infectious 
Conditions Under Public Health Surveillance”2 (see Section II for criteria). 
   
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., 
a known contact to an active TB case or a person with signs/symptoms consistent 
with TB) who is currently under evaluation for TB disease. 
 
Verification of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a 
TB control official who is familiar with TB surveillance definitions; if all the 
criteria for a TB case are met, the TB case is then verified and eligible for 
counting.  
  
Counting of a TB case - the process whereby a reporting area with count 
authority evaluates verified TB cases (e.g., assesses for case duplication). These 
cases are then counted for morbidity in that locality (e.g., state or county) and 
reported to CDC for national morbidity counting. 
  
Mycobacterium tuberculosis complex (M. tuberculosis complex) - consists of three 
mycobacterial species: M. tuberculosis, M. bovis, and M. africanum. These species are 
identical in DNA homology studies. In terms of their ability to cause clinical disease and 
to be transmissible from person to person, M. bovis and M. africanum behave like M. 
tuberculosis; therefore, disease caused by any of the three organisms should be reported 
as TB, using the Report of Verified Case of Tuberculosis (RVCT). The only exception is 
the BCG strain of M. bovis, which may be isolated from persons who have received the 
vaccine to protect against TB or as cancer immunotherapy; disease caused by this M. 
bovis strain should not be reported as TB because the transmission is iatrogenic 
(treatment-induced), rather than person-to-person or communicable. 
  Nontuberculous mycobacteria (NTM) - mycobacteria other than 
Mycobacterium tuberculosis complex that can cause human infection or disease. 
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Common  nontuberculous mycobacteria include M. avium complex or MAC 
(M. avium, M. intracellulare), M. kansasii, M. marinum, M. scrofulaceum, M. 
chelonae, M. fortuitum, and M. simiae. Other terms have been used to represent 
NTM, including MOTT (mycobacteria other than TB) and “atypical” 
mycobacteria. 
  
Reporting area - areas responsible for counting and reporting verified TB cases 
to CDC. Currently there are 59 reporting areas; 50 states, District of Columbia, 
New York City, American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin 
Islands. Annual incidence of tuberculosis for the United States is based on 52 
reporting areas (50 states, District of Columbia, and New York City). 
  
Alien - defined by the Immigration and Naturalization Service (INS)4 as “any 
person not a citizen or national of the United States.” 
  
Border crosser - defined, in part, by the Immigration and Naturalization Service 
(INS)4 as “a nonresident alien entering the United States across the Mexican 
border for stays of no more than 72 hours.” Border crossers may go back and 
forth across the border many times in a short period. 
 
Class A (TB, Infectious) - defined by the Division of Quarantine3 as an alien 
“with an abnormal chest radiograph or series of chest radiographs suggestive of 
current pulmonary TB and one or more positive sputum smear examinations for 
acid-fast bacilli.” This person is not authorized to enter the United States unless a 
waiver has been granted (see definition for Class A - TB, Infectious, 
“Noncommunicable for travel purposes.”) 
 
Class A (TB, Infectious, “Noncommunicable for travel purposes”) - defined 
by the Division of Quarantine3 as an alien “with an abnormal chest radiograph or 
series of chest radiographs suggestive of active TB, a history of one or more 
positive sputum smear examinations for acid-fast bacilli, currently on 
recommended treatment, and sputum smears that are negative for acid-fast bacilli 
on 3 consecutive days.” This person is authorized to enter the United States if a 
waiver has been granted. 
  
Class B1 (TB, clinically active, not infectious) - defined by the Division of 
Quarantine3 as an alien “with an abnormal chest radiograph or series of chest 
radiographs suggestive of active TB, and sputum smears that are negative for 
acid-fast bacilli on 3 consecutive days.” This person may be on anti-TB 
medications when entering the United States. 
 
Class B1 (Extrapulmonary TB, clinically active, not infectious) - defined by 
the Division of Quarantine3 as an alien “with radiographic or other evidence of 
extrapulmonary TB, clinically active.” This person may be on anti-TB 
medications when entering the United States.  
  
Class B2 (TB, not clinically active) - defined by the Division of Quarantine3 as 
an alien “with an abnormal chest radiograph or series of chest radiographs 
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suggestive of active TB, not clinically active (e.g., fibrosis, scarring, pleural 
thickening, diaphragmatic tenting, blunting of costophrenic angles.) Sputum 
smears are not required.” Such a person who “completed the recommended 
course of anti-TB therapy and whose chest radiographs are stable should be 
reported as Class B2 - TB, treatment completed.” This person may be on anti-TB 
medications when entering the United States. 
  
Class B3 (Consistent with TB, old or healed) - defined by the Division of 
Quarantine3 as an alien “with an abnormal chest radiograph or series of chest 
radiographs (the only abnormality is a calcified lymph node, calcified primary 
complex, or calcified granuloma). Sputum smears are not required.” 
  
Immigrant - defined by the Immigration and Naturalization Service (INS)4 as 
“an alien admitted to the United States as a lawful permanent resident. 
Immigrants are those persons lawfully accorded the privilege of residing 
permanently in the United States. They may be issued immigrant visas by the 
Department of State overseas or adjusted to permanent resident status by the 
Immigration and Naturalization Service of the United States.” 
  
Permanent Resident Alien - see Immigrant.  
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